{"took":279,"timed_out":false,"_shards":{"total":50,"successful":50,"skipped":0,"failed":0},"hits":{"total":{"value":308,"relation":"eq"},"max_score":26.449286,"hits":[{"_index":"edgar_file","_id":"0001231919-25-000459:form4-11132025_121146.xml","_score":26.449286,"_source":{"ciks":["0001134655","0001263048","0001687078","0001857903","0001719960","0001721036","0001691428","0001785530"],"period_ending":"2025-11-07","file_num":["001-40366","001-40366","001-40366","001-40366","001-40366","001-40366","001-40366"],"display_names":["GADICKE ANSBERT  (CIK 0001134655)","MPM ASSET MANAGEMENT LLC  (CIK 0001263048)","MPM BioImpact LLC  (CIK 0001687078)","MPM Oncology Innovations Fund GP LLC  (CIK 0001857903)","MPM ONCOLOGY INNOVATIONS FUND LP  (CIK 0001719960)","Oncology Impact Fund (Cayman) Management L.P.  (CIK 0001721036)","UBS Oncology Impact Fund L.P.  (CIK 0001691428)","Werewolf Therapeutics, Inc.  (HOWL)  (CIK 0001785530)"],"xsl":"xslF345X05","schema_version":"X0508","sequence":1,"root_forms":["4"],"file_date":"2025-11-12","biz_states":["MA"],"sics":["2834"],"form":"4","adsh":"0001231919-25-000459","film_num":["251474897","251474891","251474893","251474892","251474896","251474894","251474895"],"biz_locations":["","Boston, MA","Boston, MA","Boston, MA","Cambridge, MA","Cambridge, MA","Boston, MA","Watertown, MA"],"file_type":"4","file_description":null,"inc_states":["","DE","DE","DE","DE","E9","E9","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001209191-23-034346:doc4.xml","_score":25.979975,"_source":{"ciks":["0001687078","0001691428","0001721036","0001750019"],"period_ending":"2023-06-01","file_num":["001-38811","001-38811","001-38811"],"display_names":["BioImpact Capital LLC  (CIK 0001687078)","UBS Oncology Impact Fund L.P.  (CIK 0001691428)","Oncology Impact Fund (Cayman) Management L.P.  (CIK 0001721036)","TCR2 THERAPEUTICS INC.  (CIK 0001750019)"],"xsl":"xslF345X04","schema_version":"X0407","sequence":1,"root_forms":["4"],"file_date":"2023-06-05","biz_states":["MA"],"sics":["2836"],"form":"4","adsh":"0001209191-23-034346","film_num":["23993111","23993113","23993112"],"biz_locations":["Boston, MA","Cambridge, MA","Cambridge, MA","Cambridge, MA"],"file_type":"4","file_description":"FORM 4 SUBMISSION","inc_states":["DE","E9","E9","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001231919-25-000439:form4-11072025_121138.xml","_score":25.776941,"_source":{"ciks":["0001134655","0001263048","0001687078","0001857903","0001719960","0001721036","0001691428","0001785530"],"period_ending":"2025-11-04","file_num":["001-40366","001-40366","001-40366","001-40366","001-40366","001-40366","001-40366"],"display_names":["GADICKE ANSBERT  (CIK 0001134655)","MPM ASSET MANAGEMENT LLC  (CIK 0001263048)","MPM BioImpact LLC  (CIK 0001687078)","MPM Oncology Innovations Fund GP LLC  (CIK 0001857903)","MPM ONCOLOGY INNOVATIONS FUND LP  (CIK 0001719960)","Oncology Impact Fund (Cayman) Management L.P.  (CIK 0001721036)","UBS Oncology Impact Fund L.P.  (CIK 0001691428)","Werewolf Therapeutics, Inc.  (CIK 0001785530)"],"xsl":"xslF345X05","schema_version":"X0508","sequence":1,"root_forms":["4"],"file_date":"2025-11-06","biz_states":["MA"],"sics":["2834"],"form":"4","adsh":"0001231919-25-000439","film_num":["251460066","251460060","251460062","251460061","251460065","251460063","251460064"],"biz_locations":["","Boston, MA","Boston, MA","Boston, MA","Cambridge, MA","Cambridge, MA","Boston, MA","Watertown, MA"],"file_type":"4","file_description":null,"inc_states":["","DE","DE","DE","DE","E9","E9","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001231919-25-000373:form4-10292025_111002.xml","_score":25.770952,"_source":{"ciks":["0001134655","0001263048","0001687078","0001857903","0001719960","0001721036","0001691428","0001785530"],"period_ending":"2025-10-27","file_num":["001-40366","001-40366","001-40366","001-40366","001-40366","001-40366","001-40366"],"display_names":["GADICKE ANSBERT  (CIK 0001134655)","MPM ASSET MANAGEMENT LLC  (CIK 0001263048)","MPM BioImpact LLC  (CIK 0001687078)","MPM Oncology Innovations Fund GP LLC  (CIK 0001857903)","MPM ONCOLOGY INNOVATIONS FUND LP  (CIK 0001719960)","Oncology Impact Fund (Cayman) Management L.P.  (CIK 0001721036)","UBS Oncology Impact Fund L.P.  (CIK 0001691428)","Werewolf Therapeutics, Inc.  (CIK 0001785530)"],"xsl":"xslF345X05","schema_version":"X0508","sequence":1,"root_forms":["4"],"file_date":"2025-10-29","biz_states":["MA"],"sics":["2834"],"form":"4","adsh":"0001231919-25-000373","film_num":["251431631","251431625","251431627","251431626","251431630","251431628","251431629"],"biz_locations":["","Boston, MA","Boston, MA","Boston, MA","Cambridge, MA","Cambridge, MA","Boston, MA","Watertown, MA"],"file_type":"4","file_description":null,"inc_states":["","DE","DE","DE","DE","E9","E9","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001231919-25-000534:form4-11202025_101124.xml","_score":25.24231,"_source":{"ciks":["0001609492","0001609493","0001609495","0001765021","0001765091","0001785530"],"period_ending":"2025-11-18","file_num":["001-40366","001-40366","001-40366","001-40366","001-40366"],"display_names":["MPM BioVentures 2014, L.P.  (CIK 0001609492)","MPM BioVentures 2014 (B), L.P.  (CIK 0001609493)","MPM Asset Management Investors BV2014 LLC  (CIK 0001609495)","MPM BioVentures 2014 LLC  (CIK 0001765021)","MPM BioVentures 2014 GP LLC  (CIK 0001765091)","Werewolf Therapeutics, Inc.  (CIK 0001785530)"],"xsl":"xslF345X05","schema_version":"X0508","sequence":1,"root_forms":["4"],"file_date":"2025-11-20","biz_states":["MA"],"sics":["2834"],"form":"4","adsh":"0001231919-25-000534","film_num":["251504139","251504138","251504135","251504137","251504136"],"biz_locations":["Boston, MA","Boston, MA","Boston, MA","Boston, MA","Boston, MA","Watertown, MA"],"file_type":"4","file_description":null,"inc_states":["DE","DE","DE","DE","DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001231919-25-000550:form4-11252025_111145.xml","_score":25.229599,"_source":{"ciks":["0001134655","0001263048","0001687078","0001857903","0001719960","0001721036","0001691428","0001785530"],"period_ending":"2025-11-21","file_num":["001-40366","001-40366","001-40366","001-40366","001-40366","001-40366","001-40366"],"display_names":["GADICKE ANSBERT  (CIK 0001134655)","MPM ASSET MANAGEMENT LLC  (CIK 0001263048)","MPM BioImpact LLC  (CIK 0001687078)","MPM Oncology Innovations Fund GP LLC  (CIK 0001857903)","MPM ONCOLOGY INNOVATIONS FUND LP  (CIK 0001719960)","Oncology Impact Fund (Cayman) Management L.P.  (CIK 0001721036)","UBS Oncology Impact Fund L.P.  (CIK 0001691428)","Werewolf Therapeutics, Inc.  (CIK 0001785530)"],"xsl":"xslF345X05","schema_version":"X0508","sequence":1,"root_forms":["4"],"file_date":"2025-11-25","biz_states":["MA"],"sics":["2834"],"form":"4","adsh":"0001231919-25-000550","film_num":["251522990","251522984","251522986","251522985","251522989","251522987","251522988"],"biz_locations":["","Boston, MA","Boston, MA","Boston, MA","Cambridge, MA","Cambridge, MA","Boston, MA","Watertown, MA"],"file_type":"4","file_description":null,"inc_states":["","DE","DE","DE","DE","E9","E9","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001209191-21-056914:doc4.xml","_score":25.122013,"_source":{"ciks":["0001687078","0001691428","0001721036","0001789972"],"period_ending":"2021-09-16","file_num":["001-39856","001-39856","001-39856"],"display_names":["BioImpact Capital LLC  (CIK 0001687078)","UBS Oncology Impact Fund L.P.  (CIK 0001691428)","Oncology Impact Fund (Cayman) Management L.P.  (CIK 0001721036)","Cullinan Oncology, Inc.  (CGEM)  (CIK 0001789972)"],"xsl":"xslF345X03","schema_version":"X0306","sequence":1,"root_forms":["4"],"file_date":"2021-09-20","biz_states":["MA"],"sics":["2836"],"form":"4","adsh":"0001209191-21-056914","film_num":["211264193","211264195","211264194"],"biz_locations":["Cambridge, MA","Cambridge, MA","Cambridge, MA","Cambridge, MA"],"file_type":"4","file_description":"FORM 4 SUBMISSION","inc_states":["DE","E9","E9"],"items":[]}},{"_index":"edgar_file","_id":"0001193125-23-165450:d498852dsc13d.htm","_score":25.022816,"_source":{"ciks":["0001865482","0001687078"],"period_ending":null,"file_num":["005-94088"],"display_names":["Reunion Neuroscience Inc.  (CIK 0001865482)","BioImpact Capital LLC  (CIK 0001687078)"],"xsl":null,"sequence":1,"root_forms":["SC 13D"],"file_date":"2023-06-12","biz_states":["A6","MA"],"sics":["8000"],"form":"SC 13D","adsh":"0001193125-23-165450","film_num":["231009466"],"biz_locations":["Toronto, A6","Boston, MA"],"file_type":"SC 13D","file_description":"SC 13D","inc_states":["Z4","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001209191-21-054518:doc4.xml","_score":25.00771,"_source":{"ciks":["0001687078","0001691428","0001721036","0001789972"],"period_ending":"2021-08-31","file_num":["001-39856","001-39856","001-39856"],"display_names":["BioImpact Capital LLC  (CIK 0001687078)","UBS Oncology Impact Fund L.P.  (CIK 0001691428)","Oncology Impact Fund (Cayman) Management L.P.  (CIK 0001721036)","Cullinan Oncology, Inc.  (CGEM)  (CIK 0001789972)"],"xsl":"xslF345X03","schema_version":"X0306","sequence":1,"root_forms":["4"],"file_date":"2021-09-02","biz_states":["MA"],"sics":["2836"],"form":"4","adsh":"0001209191-21-054518","film_num":["211234246","211234248","211234247"],"biz_locations":["Cambridge, MA","Cambridge, MA","Cambridge, MA","Cambridge, MA"],"file_type":"4","file_description":"FORM 4 SUBMISSION","inc_states":["DE","E9","E9"],"items":[]}},{"_index":"edgar_file","_id":"0001415889-24-029141:form4-12122024_051201.xml","_score":24.985214,"_source":{"ciks":["0001134655","0001134657","0001473930","0001609492","0001609493","0001765091","0001609495","0001729504","0001734817","0001765021","0001689375"],"period_ending":"2024-12-10","file_num":["001-40969","001-40969","001-40969","001-40969","001-40969","001-40969","001-40969","001-40969","001-40969","001-40969"],"display_names":["GADICKE ANSBERT  (CIK 0001134655)","EVNIN LUKE  (CIK 0001134657)","Foley Todd  (CIK 0001473930)","MPM BioVentures 2014, L.P.  (CIK 0001609492)","MPM BioVentures 2014 (B), L.P.  (CIK 0001609493)","MPM BioVentures 2014 GP LLC  (CIK 0001765091)","MPM Asset Management Investors BV2014 LLC  (CIK 0001609495)","MPM BIOVENTURES 2018 (B), L.P.  (CIK 0001729504)","MPM ASSET MANAGEMENT INVESTORS BV2018 LLC  (CIK 0001734817)","MPM BioVentures 2014 LLC  (CIK 0001765021)","Entrada Therapeutics, Inc.  (CIK 0001689375)"],"xsl":"xslF345X05","schema_version":"X0508","sequence":1,"root_forms":["4"],"file_date":"2024-12-12","biz_states":["MA"],"sics":["2834"],"form":"4","adsh":"0001415889-24-029141","film_num":["241545704","241545705","241545703","241545706","241545702","241545699","241545701","241545698","241545697","241545700"],"biz_locations":["","","","Cambridge, MA","Cambridge, MA","Cambridge, MA","Cambridge, MA","Cambridge, MA","Cambridge, MA","Cambridge, MA","Boston, MA"],"file_type":"4","file_description":null,"inc_states":["","","","DE","DE","DE","DE","DE","DE","DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001231919-25-000507:form4-11182025_121121.xml","_score":24.803339,"_source":{"ciks":["0001134655","0001263048","0001687078","0001857903","0001719960","0001721036","0001691428","0001785530"],"period_ending":"2025-11-13","file_num":["001-40366","001-40366","001-40366","001-40366","001-40366","001-40366","001-40366"],"display_names":["GADICKE ANSBERT  (CIK 0001134655)","MPM ASSET MANAGEMENT LLC  (CIK 0001263048)","MPM BioImpact LLC  (CIK 0001687078)","MPM Oncology Innovations Fund GP LLC  (CIK 0001857903)","MPM ONCOLOGY INNOVATIONS FUND LP  (CIK 0001719960)","Oncology Impact Fund (Cayman) Management L.P.  (CIK 0001721036)","UBS Oncology Impact Fund L.P.  (CIK 0001691428)","Werewolf Therapeutics, Inc.  (HOWL)  (CIK 0001785530)"],"xsl":"xslF345X05","schema_version":"X0508","sequence":1,"root_forms":["4"],"file_date":"2025-11-17","biz_states":["MA"],"sics":["2834"],"form":"4","adsh":"0001231919-25-000507","film_num":["251492460","251492454","251492456","251492455","251492459","251492457","251492458"],"biz_locations":["","Boston, MA","Boston, MA","Boston, MA","Cambridge, MA","Cambridge, MA","Boston, MA","Watertown, MA"],"file_type":"4","file_description":null,"inc_states":["","DE","DE","DE","DE","E9","E9","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001231919-25-000551:form4-11252025_111135.xml","_score":24.71794,"_source":{"ciks":["0001609492","0001609493","0001609495","0001765021","0001765091","0001785530"],"period_ending":"2025-11-21","file_num":["001-40366","001-40366","001-40366","001-40366","001-40366"],"display_names":["MPM BioVentures 2014, L.P.  (CIK 0001609492)","MPM BioVentures 2014 (B), L.P.  (CIK 0001609493)","MPM Asset Management Investors BV2014 LLC  (CIK 0001609495)","MPM BioVentures 2014 LLC  (CIK 0001765021)","MPM BioVentures 2014 GP LLC  (CIK 0001765091)","Werewolf Therapeutics, Inc.  (CIK 0001785530)"],"xsl":"xslF345X05","schema_version":"X0508","sequence":1,"root_forms":["4"],"file_date":"2025-11-25","biz_states":["MA"],"sics":["2834"],"form":"4","adsh":"0001231919-25-000551","film_num":["251522996","251522995","251522992","251522994","251522993"],"biz_locations":["Boston, MA","Boston, MA","Boston, MA","Boston, MA","Boston, MA","Watertown, MA"],"file_type":"4","file_description":null,"inc_states":["DE","DE","DE","DE","DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001209191-21-059421:doc4.xml","_score":24.605389,"_source":{"ciks":["0001134655","0001687078","0001691428","0001721036","0001808865"],"period_ending":"2021-10-01","file_num":["001-39401","001-39401","001-39401","001-39401"],"display_names":["GADICKE ANSBERT  (CIK 0001134655)","BioImpact Capital LLC  (CIK 0001687078)","UBS Oncology Impact Fund L.P.  (CIK 0001691428)","Oncology Impact Fund (Cayman) Management L.P.  (CIK 0001721036)","iTeos Therapeutics, Inc.  (ITOS)  (CIK 0001808865)"],"xsl":"xslF345X03","schema_version":"X0306","sequence":1,"root_forms":["4"],"file_date":"2021-10-05","biz_states":["MA"],"sics":["2836"],"form":"4","adsh":"0001209191-21-059421","film_num":["211307121","211307119","211307120","211307118"],"biz_locations":["","Cambridge, MA","Cambridge, MA","Cambridge, MA","Cambridge, MA"],"file_type":"4","file_description":"FORM 4 SUBMISSION","inc_states":["","DE","E9","E9","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001567619-21-022381:primary_doc.xml","_score":24.534721,"_source":{"ciks":["0001807882"],"period_ending":null,"file_num":["021-363866"],"display_names":["BioImpact Equities Fund, LP  (CIK 0001807882)"],"xsl":"xslFormDX01","schema_version":"X0708","sequence":1,"root_forms":["D"],"file_date":"2021-12-21","biz_states":["MA"],"sics":[],"form":"D/A","adsh":"0001567619-21-022381","film_num":["211508560"],"biz_locations":["Boston, MA"],"file_type":"D/A","file_description":null,"inc_states":["DE"],"items":["06B","3C.7"]}},{"_index":"edgar_file","_id":"0001231919-25-000574:form4-12042025_111237.xml","_score":24.456936,"_source":{"ciks":["0001134655","0001263048","0001687078","0001857903","0001719960","0001721036","0001691428","0001785530"],"period_ending":"2025-12-02","file_num":["001-40366","001-40366","001-40366","001-40366","001-40366","001-40366","001-40366"],"display_names":["GADICKE ANSBERT  (CIK 0001134655)","MPM ASSET MANAGEMENT LLC  (CIK 0001263048)","MPM BioImpact LLC  (CIK 0001687078)","MPM Oncology Innovations Fund GP LLC  (CIK 0001857903)","MPM ONCOLOGY INNOVATIONS FUND LP  (CIK 0001719960)","Oncology Impact Fund (Cayman) Management L.P.  (CIK 0001721036)","UBS Oncology Impact Fund L.P.  (CIK 0001691428)","Werewolf Therapeutics, Inc.  (CIK 0001785530)"],"xsl":"xslF345X05","schema_version":"X0508","sequence":1,"root_forms":["4"],"file_date":"2025-12-04","biz_states":["MA"],"sics":["2834"],"form":"4","adsh":"0001231919-25-000574","film_num":["251550861","251550855","251550857","251550856","251550860","251550858","251550859"],"biz_locations":["","Boston, MA","Boston, MA","Boston, MA","Cambridge, MA","Cambridge, MA","Boston, MA","Watertown, MA"],"file_type":"4","file_description":null,"inc_states":["","DE","DE","DE","DE","E9","E9","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001415889-25-013252:form4-05152025_090510.xml","_score":24.36783,"_source":{"ciks":["0001134655","0001687078","0001691428","0001721036","0001808865"],"period_ending":"2025-05-13","file_num":["001-39401","001-39401","001-39401","001-39401"],"display_names":["GADICKE ANSBERT  (CIK 0001134655)","MPM BioImpact LLC  (CIK 0001687078)","UBS Oncology Impact Fund L.P.  (CIK 0001691428)","Oncology Impact Fund (Cayman) Management L.P.  (CIK 0001721036)","iTeos Therapeutics, Inc.  (CIK 0001808865)"],"xsl":"xslF345X05","schema_version":"X0508","sequence":1,"root_forms":["4"],"file_date":"2025-05-15","biz_states":["MA"],"sics":["2836"],"form":"4","adsh":"0001415889-25-013252","film_num":["25956086","25956085","25956083","25956084"],"biz_locations":["","Boston, MA","Boston, MA","Cambridge, MA","Watertown, MA"],"file_type":"4","file_description":null,"inc_states":["","DE","E9","E9","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001231919-26-000024:form3-01092026_020142.xml","_score":24.343401,"_source":{"ciks":["0001134657","0001719960","0001729504","0001729505","0001734817","0001818701","0001818702","0001857903","0002035832"],"period_ending":"2026-01-08","file_num":["001-43047","001-43047","001-43047","001-43047","001-43047","001-43047","001-43047","001-43047"],"display_names":["EVNIN LUKE  (CIK 0001134657)","MPM ONCOLOGY INNOVATIONS FUND LP  (CIK 0001719960)","MPM BIOVENTURES 2018 (B), L.P.  (CIK 0001729504)","MPM BIOVENTURES 2018, L.P.  (CIK 0001729505)","MPM ASSET MANAGEMENT INVESTORS BV2018 LLC  (CIK 0001734817)","MPM BioVentures 2018 GP LLC  (CIK 0001818701)","MPM BioVentures 2018 LLC  (CIK 0001818702)","MPM Oncology Innovations Fund GP LLC  (CIK 0001857903)","Aktis Oncology, Inc.  (CIK 0002035832)"],"xsl":"xslF345X02","schema_version":"X0206","sequence":1,"root_forms":["3"],"file_date":"2026-01-08","biz_states":["MA"],"sics":["2834"],"form":"3","adsh":"0001231919-26-000024","film_num":["26521179","26521181","26521185","26521186","26521184","26521183","26521182","26521180"],"biz_locations":["","Cambridge, MA","Cambridge, MA","Cambridge, MA","Cambridge, MA","Boston, MA","Cambridge, MA","Boston, MA","Boston, MA"],"file_type":"3","file_description":null,"inc_states":["","DE","DE","DE","DE","DE","DE","DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001231919-25-000441:form4-11072025_121141.xml","_score":24.277304,"_source":{"ciks":["0001609492","0001609493","0001609495","0001765021","0001765091","0001785530"],"period_ending":"2025-11-04","file_num":["001-40366","001-40366","001-40366","001-40366","001-40366"],"display_names":["MPM BioVentures 2014, L.P.  (CIK 0001609492)","MPM BioVentures 2014 (B), L.P.  (CIK 0001609493)","MPM Asset Management Investors BV2014 LLC  (CIK 0001609495)","MPM BioVentures 2014 LLC  (CIK 0001765021)","MPM BioVentures 2014 GP LLC  (CIK 0001765091)","Werewolf Therapeutics, Inc.  (CIK 0001785530)"],"xsl":"xslF345X05","schema_version":"X0508","sequence":1,"root_forms":["4"],"file_date":"2025-11-06","biz_states":["MA"],"sics":["2834"],"form":"4","adsh":"0001231919-25-000441","film_num":["251460071","251460070","251460067","251460069","251460068"],"biz_locations":["Boston, MA","Boston, MA","Boston, MA","Boston, MA","Boston, MA","Watertown, MA"],"file_type":"4","file_description":null,"inc_states":["DE","DE","DE","DE","DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001415889-24-030162:primary_doc.xml","_score":24.23851,"_source":{"ciks":["0001808158","0001609492"],"period_ending":null,"file_num":["005-91542"],"display_names":["Repare Therapeutics Inc.  (RPTX)  (CIK 0001808158)","MPM BioVentures 2014, L.P.  (CIK 0001609492)"],"xsl":"xslSCHEDULE_13D_X01","sequence":1,"root_forms":["SCHEDULE 13D"],"file_date":"2024-12-26","biz_states":["A8","MA"],"sics":["2834"],"form":"SCHEDULE 13D/A","adsh":"0001415889-24-030162","film_num":["241581431"],"biz_locations":["Saint-laurent, A8","Cambridge, MA"],"file_type":"SCHEDULE 13D/A","file_description":null,"inc_states":["Z4","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001415889-25-011569:form4-04302025_080446.xml","_score":24.18617,"_source":{"ciks":["0001134655","0001263048","0001687078","0001857903","0001719960","0001721036","0001691428","0001785530"],"period_ending":"2025-03-27","file_num":["001-40366","001-40366","001-40366","001-40366","001-40366","001-40366","001-40366"],"display_names":["GADICKE ANSBERT  (CIK 0001134655)","MPM ASSET MANAGEMENT LLC  (CIK 0001263048)","MPM BioImpact LLC  (CIK 0001687078)","MPM Oncology Innovations Fund GP LLC  (CIK 0001857903)","MPM ONCOLOGY INNOVATIONS FUND LP  (CIK 0001719960)","Oncology Impact Fund (Cayman) Management L.P.  (CIK 0001721036)","UBS Oncology Impact Fund L.P.  (CIK 0001691428)","Werewolf Therapeutics, Inc.  (CIK 0001785530)"],"xsl":"xslF345X05","schema_version":"X0508","sequence":1,"root_forms":["4"],"file_date":"2025-04-30","biz_states":["MA"],"sics":["2834"],"form":"4","adsh":"0001415889-25-011569","film_num":["25895087","25895081","25895083","25895082","25895086","25895084","25895085"],"biz_locations":["","Boston, MA","Boston, MA","Boston, MA","Cambridge, MA","Cambridge, MA","Boston, MA","Watertown, MA"],"file_type":"4","file_description":null,"inc_states":["","DE","DE","DE","DE","E9","E9","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001231919-26-001155:form4-09092026_110922.xml","_score":24.149256,"_source":{"ciks":["0001134655","0001134657","0001473930","0001609492","0001609493","0001765091","0001609495","0001729504","0001734817","0001765021","0001689375"],"period_ending":"2026-09-04","file_num":["001-40969","001-40969","001-40969","001-40969","001-40969","001-40969","001-40969","001-40969","001-40969","001-40969"],"display_names":["GADICKE ANSBERT  (CIK 0001134655)","EVNIN LUKE  (CIK 0001134657)","Foley Todd  (CIK 0001473930)","MPM BioVentures 2014, L.P.  (CIK 0001609492)","MPM BioVentures 2014 (B), L.P.  (CIK 0001609493)","MPM BioVentures 2014 GP LLC  (CIK 0001765091)","MPM Asset Management Investors BV2014 LLC  (CIK 0001609495)","MPM BIOVENTURES 2018 (B), L.P.  (CIK 0001729504)","MPM ASSET MANAGEMENT INVESTORS BV2018 LLC  (CIK 0001734817)","MPM BioVentures 2014 LLC  (CIK 0001765021)","Entrada Therapeutics, Inc.  (CIK 0001689375)"],"xsl":"xslF345X06","schema_version":"X0609","sequence":1,"root_forms":["4"],"file_date":"2026-09-09","biz_states":["MA"],"sics":["2834"],"form":"4","adsh":"0001231919-26-001155","film_num":["261369327","261369328","261369326","261369329","261369325","261369322","261369324","261369321","261369320","261369323"],"biz_locations":["","","","Boston, MA","Boston, MA","Boston, MA","Boston, MA","Cambridge, MA","Cambridge, MA","Boston, MA","Boston, MA"],"file_type":"4","file_description":null,"inc_states":["","","","DE","DE","DE","DE","DE","DE","DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001231919-25-000404:form4-11042025_121157.xml","_score":24.146032,"_source":{"ciks":["0001134655","0001263048","0001687078","0001857903","0001719960","0001721036","0001691428","0001785530"],"period_ending":"2025-10-30","file_num":["001-40366","001-40366","001-40366","001-40366","001-40366","001-40366","001-40366"],"display_names":["GADICKE ANSBERT  (CIK 0001134655)","MPM ASSET MANAGEMENT LLC  (CIK 0001263048)","MPM BioImpact LLC  (CIK 0001687078)","MPM Oncology Innovations Fund GP LLC  (CIK 0001857903)","MPM ONCOLOGY INNOVATIONS FUND LP  (CIK 0001719960)","Oncology Impact Fund (Cayman) Management L.P.  (CIK 0001721036)","UBS Oncology Impact Fund L.P.  (CIK 0001691428)","Werewolf Therapeutics, Inc.  (CIK 0001785530)"],"xsl":"xslF345X05","schema_version":"X0508","sequence":1,"root_forms":["4"],"file_date":"2025-11-03","biz_states":["MA"],"sics":["2834"],"form":"4","adsh":"0001231919-25-000404","film_num":["251445799","251445793","251445795","251445794","251445798","251445796","251445797"],"biz_locations":["","Boston, MA","Boston, MA","Boston, MA","Cambridge, MA","Cambridge, MA","Boston, MA","Watertown, MA"],"file_type":"4","file_description":null,"inc_states":["","DE","DE","DE","DE","E9","E9","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001415889-25-002471:primary_doc.xml","_score":24.04066,"_source":{"ciks":["0001808158","0001609492"],"period_ending":null,"file_num":["005-91542"],"display_names":["Repare Therapeutics Inc.  (RPTX)  (CIK 0001808158)","MPM BioVentures 2014, L.P.  (CIK 0001609492)"],"xsl":"xslSCHEDULE_13D_X01","sequence":1,"root_forms":["SCHEDULE 13D"],"file_date":"2025-01-31","biz_states":["A8","MA"],"sics":["2834"],"form":"SCHEDULE 13D/A","adsh":"0001415889-25-002471","film_num":["25578566"],"biz_locations":["Saint-laurent, A8","Boston, MA"],"file_type":"SCHEDULE 13D/A","file_description":null,"inc_states":["Z4","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001209191-22-002167:doc4.xml","_score":23.985373,"_source":{"ciks":["0001134655","0001687078","0001691428","0001721036","0001808865"],"period_ending":"2022-01-04","file_num":["001-39401","001-39401","001-39401","001-39401"],"display_names":["GADICKE ANSBERT  (CIK 0001134655)","BioImpact Capital LLC  (CIK 0001687078)","UBS Oncology Impact Fund L.P.  (CIK 0001691428)","Oncology Impact Fund (Cayman) Management L.P.  (CIK 0001721036)","iTeos Therapeutics, Inc.  (ITOS)  (CIK 0001808865)"],"xsl":"xslF345X03","schema_version":"X0306","sequence":1,"root_forms":["4"],"file_date":"2022-01-06","biz_states":["MA"],"sics":["2836"],"form":"4","adsh":"0001209191-22-002167","film_num":["22514946","22514944","22514945","22514943"],"biz_locations":["","Cambridge, MA","Cambridge, MA","Cambridge, MA","Cambridge, MA"],"file_type":"4","file_description":"FORM 4 SUBMISSION","inc_states":["","DE","E9","E9","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001415889-25-004105:primary_doc.xml","_score":23.963276,"_source":{"ciks":["0001738021","0001687078"],"period_ending":null,"file_num":["005-90878"],"display_names":["Compass Therapeutics, Inc.  (CMPX)  (CIK 0001738021)","MPM BioImpact LLC  (CIK 0001687078)"],"xsl":"xslSCHEDULE_13G_X01","sequence":1,"root_forms":["SCHEDULE 13G"],"file_date":"2025-02-14","biz_states":["MA"],"sics":["2836"],"form":"SCHEDULE 13G","adsh":"0001415889-25-004105","film_num":["25628683"],"biz_locations":["Boston, MA","Boston, MA"],"file_type":"SCHEDULE 13G","file_description":null,"inc_states":["DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001609492-26-000002:primary_doc.xml","_score":23.934523,"_source":{"ciks":["0001785530","0001609492"],"period_ending":null,"file_num":["005-92515"],"display_names":["Werewolf Therapeutics, Inc.  (HOWL)  (CIK 0001785530)","MPM BioVentures 2014, L.P.  (CIK 0001609492)"],"xsl":"xslSCHEDULE_13D_X01","sequence":1,"root_forms":["SCHEDULE 13D"],"file_date":"2026-01-16","biz_states":["MA"],"sics":["2834"],"form":"SCHEDULE 13D/A","adsh":"0001609492-26-000002","film_num":["26540530"],"biz_locations":["Watertown, MA","Boston, MA"],"file_type":"SCHEDULE 13D/A","file_description":null,"inc_states":["DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001231919-25-000406:form4-11042025_121111.xml","_score":23.931555,"_source":{"ciks":["0001609492","0001609493","0001609495","0001765021","0001765091","0001785530"],"period_ending":"2025-10-30","file_num":["001-40366","001-40366","001-40366","001-40366","001-40366"],"display_names":["MPM BioVentures 2014, L.P.  (CIK 0001609492)","MPM BioVentures 2014 (B), L.P.  (CIK 0001609493)","MPM Asset Management Investors BV2014 LLC  (CIK 0001609495)","MPM BioVentures 2014 LLC  (CIK 0001765021)","MPM BioVentures 2014 GP LLC  (CIK 0001765091)","Werewolf Therapeutics, Inc.  (CIK 0001785530)"],"xsl":"xslF345X05","schema_version":"X0508","sequence":1,"root_forms":["4"],"file_date":"2025-11-03","biz_states":["MA"],"sics":["2834"],"form":"4","adsh":"0001231919-25-000406","film_num":["251445807","251445806","251445803","251445805","251445804"],"biz_locations":["Boston, MA","Boston, MA","Boston, MA","Boston, MA","Boston, MA","Watertown, MA"],"file_type":"4","file_description":null,"inc_states":["DE","DE","DE","DE","DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001231919-25-000511:primary_doc.xml","_score":23.928305,"_source":{"ciks":["0001785530","0001609492"],"period_ending":null,"file_num":["005-92515"],"display_names":["Werewolf Therapeutics, Inc.  (HOWL)  (CIK 0001785530)","MPM BioVentures 2014, L.P.  (CIK 0001609492)"],"xsl":"xslSCHEDULE_13D_X01","sequence":1,"root_forms":["SCHEDULE 13D"],"file_date":"2025-11-17","biz_states":["MA"],"sics":["2834"],"form":"SCHEDULE 13D/A","adsh":"0001231919-25-000511","film_num":["251492515"],"biz_locations":["Watertown, MA","Boston, MA"],"file_type":"SCHEDULE 13D/A","file_description":null,"inc_states":["DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001415889-25-001509:ex-1-01152025_110127.htm","_score":23.886461,"_source":{"ciks":["0001808158","0001609492"],"period_ending":null,"file_num":["005-91542"],"display_names":["Repare Therapeutics Inc.  (RPTX)  (CIK 0001808158)","MPM BioVentures 2014, L.P.  (CIK 0001609492)"],"xsl":null,"sequence":"2","root_forms":["SCHEDULE 13D"],"file_date":"2025-01-15","biz_states":["A8","MA"],"sics":["2834"],"form":"SCHEDULE 13D/A","adsh":"0001415889-25-001509","film_num":["25533970"],"biz_locations":["Saint-laurent, A8","Cambridge, MA"],"file_type":"EX-1","file_description":"JOINT FILING STATEMENT","inc_states":["Z4","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001231919-25-000564:form4-12012025_111253.xml","_score":23.880465,"_source":{"ciks":["0001134655","0001263048","0001687078","0001857903","0001719960","0001721036","0001691428","0001785530"],"period_ending":"2025-11-26","file_num":["001-40366","001-40366","001-40366","001-40366","001-40366","001-40366","001-40366"],"display_names":["GADICKE ANSBERT  (CIK 0001134655)","MPM ASSET MANAGEMENT LLC  (CIK 0001263048)","MPM BioImpact LLC  (CIK 0001687078)","MPM Oncology Innovations Fund GP LLC  (CIK 0001857903)","MPM ONCOLOGY INNOVATIONS FUND LP  (CIK 0001719960)","Oncology Impact Fund (Cayman) Management L.P.  (CIK 0001721036)","UBS Oncology Impact Fund L.P.  (CIK 0001691428)","Werewolf Therapeutics, Inc.  (CIK 0001785530)"],"xsl":"xslF345X05","schema_version":"X0508","sequence":1,"root_forms":["4"],"file_date":"2025-12-01","biz_states":["MA"],"sics":["2834"],"form":"4","adsh":"0001231919-25-000564","film_num":["251541056","251541052","251541054","251541053","251541058","251541055","251541057"],"biz_locations":["","Boston, MA","Boston, MA","Boston, MA","Cambridge, MA","Cambridge, MA","Boston, MA","Watertown, MA"],"file_type":"4","file_description":null,"inc_states":["","DE","DE","DE","DE","E9","E9","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001231919-25-000461:form4-11132025_121151.xml","_score":23.87481,"_source":{"ciks":["0001609492","0001609493","0001609495","0001765021","0001765091","0001785530"],"period_ending":"2025-11-07","file_num":["001-40366","001-40366","001-40366","001-40366","001-40366"],"display_names":["MPM BioVentures 2014, L.P.  (CIK 0001609492)","MPM BioVentures 2014 (B), L.P.  (CIK 0001609493)","MPM Asset Management Investors BV2014 LLC  (CIK 0001609495)","MPM BioVentures 2014 LLC  (CIK 0001765021)","MPM BioVentures 2014 GP LLC  (CIK 0001765091)","Werewolf Therapeutics, Inc.  (HOWL)  (CIK 0001785530)"],"xsl":"xslF345X05","schema_version":"X0508","sequence":1,"root_forms":["4"],"file_date":"2025-11-12","biz_states":["MA"],"sics":["2834"],"form":"4","adsh":"0001231919-25-000461","film_num":["251474906","251474905","251474902","251474904","251474903"],"biz_locations":["Boston, MA","Boston, MA","Boston, MA","Boston, MA","Boston, MA","Watertown, MA"],"file_type":"4","file_description":null,"inc_states":["DE","DE","DE","DE","DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001231919-26-001143:form4-09032026_110951.xml","_score":23.845188,"_source":{"ciks":["0001134655","0001134657","0001473930","0001609492","0001609493","0001765091","0001609495","0001729504","0001734817","0001765021","0001689375"],"period_ending":"2026-09-01","file_num":["001-40969","001-40969","001-40969","001-40969","001-40969","001-40969","001-40969","001-40969","001-40969","001-40969"],"display_names":["GADICKE ANSBERT  (CIK 0001134655)","EVNIN LUKE  (CIK 0001134657)","Foley Todd  (CIK 0001473930)","MPM BioVentures 2014, L.P.  (CIK 0001609492)","MPM BioVentures 2014 (B), L.P.  (CIK 0001609493)","MPM BioVentures 2014 GP LLC  (CIK 0001765091)","MPM Asset Management Investors BV2014 LLC  (CIK 0001609495)","MPM BIOVENTURES 2018 (B), L.P.  (CIK 0001729504)","MPM ASSET MANAGEMENT INVESTORS BV2018 LLC  (CIK 0001734817)","MPM BioVentures 2014 LLC  (CIK 0001765021)","Entrada Therapeutics, Inc.  (CIK 0001689375)"],"xsl":"xslF345X06","schema_version":"X0609","sequence":1,"root_forms":["4"],"file_date":"2026-09-03","biz_states":["MA"],"sics":["2834"],"form":"4","adsh":"0001231919-26-001143","film_num":["261359761","261359762","261359760","261359763","261359759","261359756","261359758","261359755","261359754","261359757"],"biz_locations":["","","","Boston, MA","Boston, MA","Boston, MA","Boston, MA","Cambridge, MA","Cambridge, MA","Boston, MA","Boston, MA"],"file_type":"4","file_description":null,"inc_states":["","","","DE","DE","DE","DE","DE","DE","DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001231919-26-001107:form4-08272026_010802.xml","_score":23.840805,"_source":{"ciks":["0001134655","0001134657","0001473930","0001609492","0001609493","0001765091","0001609495","0001729504","0001734817","0001765021","0001689375"],"period_ending":"2026-08-24","file_num":["001-40969","001-40969","001-40969","001-40969","001-40969","001-40969","001-40969","001-40969","001-40969","001-40969"],"display_names":["GADICKE ANSBERT  (CIK 0001134655)","EVNIN LUKE  (CIK 0001134657)","Foley Todd  (CIK 0001473930)","MPM BioVentures 2014, L.P.  (CIK 0001609492)","MPM BioVentures 2014 (B), L.P.  (CIK 0001609493)","MPM BioVentures 2014 GP LLC  (CIK 0001765091)","MPM Asset Management Investors BV2014 LLC  (CIK 0001609495)","MPM BIOVENTURES 2018 (B), L.P.  (CIK 0001729504)","MPM ASSET MANAGEMENT INVESTORS BV2018 LLC  (CIK 0001734817)","MPM BioVentures 2014 LLC  (CIK 0001765021)","Entrada Therapeutics, Inc.  (CIK 0001689375)"],"xsl":"xslF345X06","schema_version":"X0609","sequence":1,"root_forms":["4"],"file_date":"2026-08-26","biz_states":["MA"],"sics":["2834"],"form":"4","adsh":"0001231919-26-001107","film_num":["261324789","261324790","261324788","261324791","261324787","261324784","261324786","261324783","261324782","261324785"],"biz_locations":["","","","Boston, MA","Boston, MA","Boston, MA","Boston, MA","Cambridge, MA","Cambridge, MA","Boston, MA","Boston, MA"],"file_type":"4","file_description":null,"inc_states":["","","","DE","DE","DE","DE","DE","DE","DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001209191-21-057413:doc4.xml","_score":23.832634,"_source":{"ciks":["0001134655","0001687078","0001691428","0001721036","0001808865"],"period_ending":"2021-09-21","file_num":["001-39401","001-39401","001-39401","001-39401"],"display_names":["GADICKE ANSBERT  (CIK 0001134655)","BioImpact Capital LLC  (CIK 0001687078)","UBS Oncology Impact Fund L.P.  (CIK 0001691428)","Oncology Impact Fund (Cayman) Management L.P.  (CIK 0001721036)","iTeos Therapeutics, Inc.  (ITOS)  (CIK 0001808865)"],"xsl":"xslF345X03","schema_version":"X0306","sequence":1,"root_forms":["4"],"file_date":"2021-09-23","biz_states":["MA"],"sics":["2836"],"form":"4","adsh":"0001209191-21-057413","film_num":["211272732","211272730","211272731","211272729"],"biz_locations":["","Cambridge, MA","Cambridge, MA","Cambridge, MA","Cambridge, MA"],"file_type":"4","file_description":"FORM 4 SUBMISSION","inc_states":["","DE","E9","E9","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001209191-21-056411:doc4.xml","_score":23.786285,"_source":{"ciks":["0001687078","0001691428","0001721036","0001789972"],"period_ending":"2021-09-14","file_num":["001-39856","001-39856","001-39856"],"display_names":["BioImpact Capital LLC  (CIK 0001687078)","UBS Oncology Impact Fund L.P.  (CIK 0001691428)","Oncology Impact Fund (Cayman) Management L.P.  (CIK 0001721036)","Cullinan Oncology, Inc.  (CGEM)  (CIK 0001789972)"],"xsl":"xslF345X03","schema_version":"X0306","sequence":1,"root_forms":["4"],"file_date":"2021-09-16","biz_states":["MA"],"sics":["2836"],"form":"4","adsh":"0001209191-21-056411","film_num":["211258417","211258419","211258418"],"biz_locations":["Cambridge, MA","Cambridge, MA","Cambridge, MA","Cambridge, MA"],"file_type":"4","file_description":"FORM 4 SUBMISSION","inc_states":["DE","E9","E9"],"items":[]}},{"_index":"edgar_file","_id":"0001193125-21-353003:d251372dsc13da.htm","_score":23.78211,"_source":{"ciks":["0001808865","0001609492"],"period_ending":null,"file_num":["005-91596"],"display_names":["iTeos Therapeutics, Inc.  (ITOS)  (CIK 0001808865)","MPM BioVentures 2014, L.P.  (CIK 0001609492)"],"xsl":null,"sequence":1,"root_forms":["SC 13D"],"file_date":"2021-12-10","biz_states":["MA"],"sics":["2836"],"form":"SC 13D/A","adsh":"0001193125-21-353003","film_num":["211483362"],"biz_locations":["Cambridge, MA","Cambridge, MA"],"file_type":"SC 13D/A","file_description":"SC 13D/A","inc_states":["DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001415889-25-013244:ex-1-05152025_090552.htm","_score":23.777842,"_source":{"ciks":["0001808865","0001609492"],"period_ending":null,"file_num":["005-91596"],"display_names":["iTeos Therapeutics, Inc.  (ITOS)  (CIK 0001808865)","MPM BioVentures 2014, L.P.  (CIK 0001609492)"],"xsl":null,"sequence":"2","root_forms":["SCHEDULE 13D"],"file_date":"2025-05-15","biz_states":["MA"],"sics":["2836"],"form":"SCHEDULE 13D/A","adsh":"0001415889-25-013244","film_num":["25956038"],"biz_locations":["Watertown, MA","Boston, MA"],"file_type":"EX-1","file_description":"JOINT FILING STATEMENT","inc_states":["DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001209191-21-055203:doc4.xml","_score":23.758333,"_source":{"ciks":["0001687078","0001691428","0001721036","0001789972"],"period_ending":"2021-09-03","file_num":["001-39856","001-39856","001-39856"],"display_names":["BioImpact Capital LLC  (CIK 0001687078)","UBS Oncology Impact Fund L.P.  (CIK 0001691428)","Oncology Impact Fund (Cayman) Management L.P.  (CIK 0001721036)","Cullinan Oncology, Inc.  (CGEM)  (CIK 0001789972)"],"xsl":"xslF345X03","schema_version":"X0306","sequence":1,"root_forms":["4"],"file_date":"2021-09-08","biz_states":["MA"],"sics":["2836"],"form":"4","adsh":"0001209191-21-055203","film_num":["211243123","211243125","211243124"],"biz_locations":["Cambridge, MA","Cambridge, MA","Cambridge, MA","Cambridge, MA"],"file_type":"4","file_description":"FORM 4 SUBMISSION","inc_states":["DE","E9","E9"],"items":[]}},{"_index":"edgar_file","_id":"0001415889-24-030162:ex-1-12262024_091203.htm","_score":23.700638,"_source":{"ciks":["0001808158","0001609492"],"period_ending":null,"file_num":["005-91542"],"display_names":["Repare Therapeutics Inc.  (RPTX)  (CIK 0001808158)","MPM BioVentures 2014, L.P.  (CIK 0001609492)"],"xsl":null,"sequence":"2","root_forms":["SCHEDULE 13D"],"file_date":"2024-12-26","biz_states":["A8","MA"],"sics":["2834"],"form":"SCHEDULE 13D/A","adsh":"0001415889-24-030162","film_num":["241581431"],"biz_locations":["Saint-laurent, A8","Cambridge, MA"],"file_type":"EX-1","file_description":"SCHEDULE I","inc_states":["Z4","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001687078-26-000007:primary_doc.xml","_score":23.686525,"_source":{"ciks":["0001613780","0001687078"],"period_ending":null,"file_num":["005-88701"],"display_names":["DBV Technologies S.A.  (DBVT, DBVTF)  (CIK 0001613780)","MPM BioImpact LLC  (CIK 0001687078)"],"xsl":"xslSCHEDULE_13G_X01","sequence":1,"root_forms":["SCHEDULE 13G"],"file_date":"2026-02-17","biz_states":["I0","MA"],"sics":["2836"],"form":"SCHEDULE 13G","adsh":"0001687078-26-000007","film_num":["26641232"],"biz_locations":["Chatillon, I0","Boston, MA"],"file_type":"SCHEDULE 13G","file_description":null,"inc_states":["I0","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001193125-21-278351:d212808dsc13da.htm","_score":23.667652,"_source":{"ciks":["0001808865","0001609492"],"period_ending":null,"file_num":["005-91596"],"display_names":["iTeos Therapeutics, Inc.  (ITOS)  (CIK 0001808865)","MPM BioVentures 2014, L.P.  (CIK 0001609492)"],"xsl":null,"sequence":1,"root_forms":["SC 13D"],"file_date":"2021-09-21","biz_states":["MA"],"sics":["2836"],"form":"SC 13D/A","adsh":"0001193125-21-278351","film_num":["211266856"],"biz_locations":["Cambridge, MA","Cambridge, MA"],"file_type":"SC 13D/A","file_description":"SC 13D/A","inc_states":["DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001231919-26-000057:form4-01142026_110117.xml","_score":23.600588,"_source":{"ciks":["0001134657","0001719960","0001729504","0001729505","0001734817","0001818701","0001818702","0001857903","0002035832"],"period_ending":"2026-01-12","file_num":["001-43047","001-43047","001-43047","001-43047","001-43047","001-43047","001-43047","001-43047"],"display_names":["EVNIN LUKE  (CIK 0001134657)","MPM ONCOLOGY INNOVATIONS FUND LP  (CIK 0001719960)","MPM BIOVENTURES 2018 (B), L.P.  (CIK 0001729504)","MPM BIOVENTURES 2018, L.P.  (CIK 0001729505)","MPM ASSET MANAGEMENT INVESTORS BV2018 LLC  (CIK 0001734817)","MPM BioVentures 2018 GP LLC  (CIK 0001818701)","MPM BioVentures 2018 LLC  (CIK 0001818702)","MPM Oncology Innovations Fund GP LLC  (CIK 0001857903)","Aktis Oncology, Inc.  (CIK 0002035832)"],"xsl":"xslF345X05","schema_version":"X0508","sequence":1,"root_forms":["4"],"file_date":"2026-01-14","biz_states":["MA"],"sics":["2834"],"form":"4","adsh":"0001231919-26-000057","film_num":["26534231","26534226","26534230","26534232","26534227","26534228","26534229","26534225"],"biz_locations":["","Cambridge, MA","Cambridge, MA","Cambridge, MA","Cambridge, MA","Boston, MA","Cambridge, MA","Boston, MA","Boston, MA"],"file_type":"4","file_description":null,"inc_states":["","DE","DE","DE","DE","DE","DE","DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0000929638-24-002291:primary_doc.xml","_score":23.59006,"_source":{"ciks":["0002028760"],"period_ending":null,"file_num":["021-517266"],"display_names":["MPM BioImpact Innovations Equities Master, LP  (CIK 0002028760)"],"xsl":"xslFormDX01","schema_version":"X0708","sequence":1,"root_forms":["D"],"file_date":"2024-06-28","biz_states":["MA"],"sics":[],"form":"D","adsh":"0000929638-24-002291","film_num":["241081728"],"biz_locations":["Boston, MA"],"file_type":"D","file_description":null,"inc_states":["DE"],"items":["06B","3C","3C.7"]}},{"_index":"edgar_file","_id":"0001231919-25-000666:primary_doc.xml","_score":23.588562,"_source":{"ciks":["0001785530","0001609492"],"period_ending":null,"file_num":["005-92515"],"display_names":["Werewolf Therapeutics, Inc.  (HOWL)  (CIK 0001785530)","MPM BioVentures 2014, L.P.  (CIK 0001609492)"],"xsl":"xslSCHEDULE_13D_X01","sequence":1,"root_forms":["SCHEDULE 13D"],"file_date":"2025-12-29","biz_states":["MA"],"sics":["2834"],"form":"SCHEDULE 13D/A","adsh":"0001231919-25-000666","film_num":["251610739"],"biz_locations":["Watertown, MA","Boston, MA"],"file_type":"SCHEDULE 13D/A","file_description":null,"inc_states":["DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001231919-26-001135:form4-08312026_100852.xml","_score":23.580181,"_source":{"ciks":["0001134655","0001134657","0001473930","0001609492","0001609493","0001765091","0001609495","0001729504","0001734817","0001765021","0001689375"],"period_ending":"2026-08-27","file_num":["001-40969","001-40969","001-40969","001-40969","001-40969","001-40969","001-40969","001-40969","001-40969","001-40969"],"display_names":["GADICKE ANSBERT  (CIK 0001134655)","EVNIN LUKE  (CIK 0001134657)","Foley Todd  (CIK 0001473930)","MPM BioVentures 2014, L.P.  (CIK 0001609492)","MPM BioVentures 2014 (B), L.P.  (CIK 0001609493)","MPM BioVentures 2014 GP LLC  (CIK 0001765091)","MPM Asset Management Investors BV2014 LLC  (CIK 0001609495)","MPM BIOVENTURES 2018 (B), L.P.  (CIK 0001729504)","MPM ASSET MANAGEMENT INVESTORS BV2018 LLC  (CIK 0001734817)","MPM BioVentures 2014 LLC  (CIK 0001765021)","Entrada Therapeutics, Inc.  (CIK 0001689375)"],"xsl":"xslF345X06","schema_version":"X0609","sequence":1,"root_forms":["4"],"file_date":"2026-08-31","biz_states":["MA"],"sics":["2834"],"form":"4","adsh":"0001231919-26-001135","film_num":["261348048","261348049","261348047","261348050","261348046","261348043","261348045","261348042","261348041","261348044"],"biz_locations":["","","","Boston, MA","Boston, MA","Boston, MA","Boston, MA","Cambridge, MA","Cambridge, MA","Boston, MA","Boston, MA"],"file_type":"4","file_description":null,"inc_states":["","","","DE","DE","DE","DE","DE","DE","DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001209191-21-060722:doc4.xml","_score":23.490194,"_source":{"ciks":["0001134655","0001687078","0001691428","0001721036","0001808865"],"period_ending":"2021-10-15","file_num":["001-39401","001-39401","001-39401","001-39401"],"display_names":["GADICKE ANSBERT  (CIK 0001134655)","BioImpact Capital LLC  (CIK 0001687078)","UBS Oncology Impact Fund L.P.  (CIK 0001691428)","Oncology Impact Fund (Cayman) Management L.P.  (CIK 0001721036)","iTeos Therapeutics, Inc.  (ITOS)  (CIK 0001808865)"],"xsl":"xslF345X03","schema_version":"X0306","sequence":1,"root_forms":["4"],"file_date":"2021-10-18","biz_states":["MA"],"sics":["2836"],"form":"4","adsh":"0001209191-21-060722","film_num":["211328586","211328584","211328585","211328583"],"biz_locations":["","Cambridge, MA","Cambridge, MA","Cambridge, MA","Cambridge, MA"],"file_type":"4","file_description":"FORM 4 SUBMISSION","inc_states":["","DE","E9","E9","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001687078-26-000006:primary_doc.xml","_score":23.465473,"_source":{"ciks":["0001768446","0001687078"],"period_ending":null,"file_num":["005-92797"],"display_names":["Climb Bio, Inc.  (CLYM)  (CIK 0001768446)","MPM BioImpact LLC  (CIK 0001687078)"],"xsl":"xslSCHEDULE_13G_X01","sequence":1,"root_forms":["SCHEDULE 13G"],"file_date":"2026-02-17","biz_states":["MA"],"sics":["2834"],"form":"SCHEDULE 13G","adsh":"0001687078-26-000006","film_num":["26641160"],"biz_locations":["Wellesley Hills, MA","Boston, MA"],"file_type":"SCHEDULE 13G","file_description":null,"inc_states":["DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001209191-21-066854:doc4.xml","_score":23.439375,"_source":{"ciks":["0001134655","0001687078","0001691428","0001721036","0001808865"],"period_ending":"2021-11-17","file_num":["001-39401","001-39401","001-39401","001-39401"],"display_names":["GADICKE ANSBERT  (CIK 0001134655)","BioImpact Capital LLC  (CIK 0001687078)","UBS Oncology Impact Fund L.P.  (CIK 0001691428)","Oncology Impact Fund (Cayman) Management L.P.  (CIK 0001721036)","iTeos Therapeutics, Inc.  (ITOS)  (CIK 0001808865)"],"xsl":"xslF345X03","schema_version":"X0306","sequence":1,"root_forms":["4"],"file_date":"2021-11-24","biz_states":["MA"],"sics":["2836"],"form":"4","adsh":"0001209191-21-066854","film_num":["211448585","211448583","211448584","211448582"],"biz_locations":["","Cambridge, MA","Cambridge, MA","Cambridge, MA","Cambridge, MA"],"file_type":"4","file_description":"FORM 4 SUBMISSION","inc_states":["","DE","E9","E9","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001231919-26-001144:form4-09032026_110942.xml","_score":23.435469,"_source":{"ciks":["0001729505","0001818702","0001818701","0001689375"],"period_ending":"2026-09-01","file_num":["001-40969","001-40969","001-40969"],"display_names":["MPM BIOVENTURES 2018, L.P.  (CIK 0001729505)","MPM BioVentures 2018 LLC  (CIK 0001818702)","MPM BioVentures 2018 GP LLC  (CIK 0001818701)","Entrada Therapeutics, Inc.  (CIK 0001689375)"],"xsl":"xslF345X06","schema_version":"X0609","sequence":1,"root_forms":["4"],"file_date":"2026-09-03","biz_states":["MA"],"sics":["2834"],"form":"4","adsh":"0001231919-26-001144","film_num":["261359767","261359766","261359765"],"biz_locations":["Cambridge, MA","Cambridge, MA","Boston, MA","Boston, MA"],"file_type":"4","file_description":null,"inc_states":["DE","DE","DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001209191-21-056948:doc4.xml","_score":23.395607,"_source":{"ciks":["0001134655","0001687078","0001691428","0001721036","0001808865"],"period_ending":"2021-09-16","file_num":["001-39401","001-39401","001-39401","001-39401"],"display_names":["GADICKE ANSBERT  (CIK 0001134655)","BioImpact Capital LLC  (CIK 0001687078)","UBS Oncology Impact Fund L.P.  (CIK 0001691428)","Oncology Impact Fund (Cayman) Management L.P.  (CIK 0001721036)","iTeos Therapeutics, Inc.  (ITOS)  (CIK 0001808865)"],"xsl":"xslF345X03","schema_version":"X0306","sequence":1,"root_forms":["4"],"file_date":"2021-09-20","biz_states":["MA"],"sics":["2836"],"form":"4","adsh":"0001209191-21-056948","film_num":["211264358","211264356","211264357","211264355"],"biz_locations":["","Cambridge, MA","Cambridge, MA","Cambridge, MA","Cambridge, MA"],"file_type":"4","file_description":"FORM 4 SUBMISSION","inc_states":["","DE","E9","E9","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001231919-25-000509:form4-11182025_121101.xml","_score":23.392506,"_source":{"ciks":["0001609492","0001609493","0001609495","0001765021","0001765091","0001785530"],"period_ending":"2025-11-13","file_num":["001-40366","001-40366","001-40366","001-40366","001-40366"],"display_names":["MPM BioVentures 2014, L.P.  (CIK 0001609492)","MPM BioVentures 2014 (B), L.P.  (CIK 0001609493)","MPM Asset Management Investors BV2014 LLC  (CIK 0001609495)","MPM BioVentures 2014 LLC  (CIK 0001765021)","MPM BioVentures 2014 GP LLC  (CIK 0001765091)","Werewolf Therapeutics, Inc.  (HOWL)  (CIK 0001785530)"],"xsl":"xslF345X05","schema_version":"X0508","sequence":1,"root_forms":["4"],"file_date":"2025-11-17","biz_states":["MA"],"sics":["2834"],"form":"4","adsh":"0001231919-25-000509","film_num":["251492466","251492465","251492462","251492464","251492463"],"biz_locations":["Boston, MA","Boston, MA","Boston, MA","Boston, MA","Boston, MA","Watertown, MA"],"file_type":"4","file_description":null,"inc_states":["DE","DE","DE","DE","DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001231919-25-000575:form4-12042025_111239.xml","_score":23.391676,"_source":{"ciks":["0001609492","0001609493","0001609495","0001765021","0001765091","0001785530"],"period_ending":"2025-12-02","file_num":["001-40366","001-40366","001-40366","001-40366","001-40366"],"display_names":["MPM BioVentures 2014, L.P.  (CIK 0001609492)","MPM BioVentures 2014 (B), L.P.  (CIK 0001609493)","MPM Asset Management Investors BV2014 LLC  (CIK 0001609495)","MPM BioVentures 2014 LLC  (CIK 0001765021)","MPM BioVentures 2014 GP LLC  (CIK 0001765091)","Werewolf Therapeutics, Inc.  (CIK 0001785530)"],"xsl":"xslF345X05","schema_version":"X0508","sequence":1,"root_forms":["4"],"file_date":"2025-12-04","biz_states":["MA"],"sics":["2834"],"form":"4","adsh":"0001231919-25-000575","film_num":["251550866","251550865","251550862","251550864","251550863"],"biz_locations":["Boston, MA","Boston, MA","Boston, MA","Boston, MA","Boston, MA","Watertown, MA"],"file_type":"4","file_description":null,"inc_states":["DE","DE","DE","DE","DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001231919-26-000055:form4-01142026_110148.xml","_score":23.379908,"_source":{"ciks":["0001134655","0002104306","0001263048","0002035832"],"period_ending":"2026-01-12","file_num":["001-43047","001-43047","001-43047"],"display_names":["GADICKE ANSBERT  (CIK 0001134655)","Oncology Impact Private Investment Fund 2, L.P.  (CIK 0002104306)","MPM ASSET MANAGEMENT LLC  (CIK 0001263048)","Aktis Oncology, Inc.  (CIK 0002035832)"],"xsl":"xslF345X05","schema_version":"X0508","sequence":1,"root_forms":["4"],"file_date":"2026-01-14","biz_states":["MA"],"sics":["2834"],"form":"4","adsh":"0001231919-26-000055","film_num":["26534223","26534221","26534222"],"biz_locations":["","Grand Cayman","Boston, MA","Boston, MA"],"file_type":"4","file_description":null,"inc_states":["","E9","DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001193125-24-032037:d777936dsc13da.htm","_score":23.332376,"_source":{"ciks":["0001708493","0001609492"],"period_ending":null,"file_num":["005-90935"],"display_names":["Harpoon Therapeutics, Inc.  (CIK 0001708493)","MPM BioVentures 2014, L.P.  (CIK 0001609492)"],"xsl":null,"sequence":1,"root_forms":["SC 13D"],"file_date":"2024-02-12","biz_states":["CA","MA"],"sics":["2836"],"form":"SC 13D/A","adsh":"0001193125-24-032037","film_num":["24619951"],"biz_locations":["South San Francisco, CA","Cambridge, MA"],"file_type":"SC 13D/A","file_description":"SC 13D/A","inc_states":["DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001415889-25-013248:form4-05152025_090517.xml","_score":23.327019,"_source":{"ciks":["0001134657","0001473930","0001609492","0001609493","0001609495","0001729504","0001734817","0001765021","0001765091","0001808865"],"period_ending":"2025-05-13","file_num":["001-39401","001-39401","001-39401","001-39401","001-39401","001-39401","001-39401","001-39401","001-39401"],"display_names":["EVNIN LUKE  (CIK 0001134657)","Foley Todd  (CIK 0001473930)","MPM BioVentures 2014, L.P.  (CIK 0001609492)","MPM BioVentures 2014 (B), L.P.  (CIK 0001609493)","MPM Asset Management Investors BV2014 LLC  (CIK 0001609495)","MPM BIOVENTURES 2018 (B), L.P.  (CIK 0001729504)","MPM ASSET MANAGEMENT INVESTORS BV2018 LLC  (CIK 0001734817)","MPM BioVentures 2014 LLC  (CIK 0001765021)","MPM BioVentures 2014 GP LLC  (CIK 0001765091)","iTeos Therapeutics, Inc.  (CIK 0001808865)"],"xsl":"xslF345X05","schema_version":"X0508","sequence":1,"root_forms":["4"],"file_date":"2025-05-15","biz_states":["MA"],"sics":["2836"],"form":"4","adsh":"0001415889-25-013248","film_num":["25956055","25956054","25956062","25956061","25956060","25956057","25956056","25956058","25956059"],"biz_locations":["","","Boston, MA","Boston, MA","Boston, MA","Cambridge, MA","Cambridge, MA","Boston, MA","Boston, MA","Watertown, MA"],"file_type":"4","file_description":null,"inc_states":["","","DE","DE","DE","DE","DE","DE","DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001231919-25-000533:form4-11202025_101121.xml","_score":23.233187,"_source":{"ciks":["0001134655","0001263048","0001687078","0001857903","0001719960","0001721036","0001691428","0001785530"],"period_ending":"2025-11-18","file_num":["001-40366","001-40366","001-40366","001-40366","001-40366","001-40366","001-40366"],"display_names":["GADICKE ANSBERT  (CIK 0001134655)","MPM ASSET MANAGEMENT LLC  (CIK 0001263048)","MPM BioImpact LLC  (CIK 0001687078)","MPM Oncology Innovations Fund GP LLC  (CIK 0001857903)","MPM ONCOLOGY INNOVATIONS FUND LP  (CIK 0001719960)","Oncology Impact Fund (Cayman) Management L.P.  (CIK 0001721036)","UBS Oncology Impact Fund L.P.  (CIK 0001691428)","Werewolf Therapeutics, Inc.  (CIK 0001785530)"],"xsl":"xslF345X05","schema_version":"X0508","sequence":1,"root_forms":["4"],"file_date":"2025-11-20","biz_states":["MA"],"sics":["2834"],"form":"4","adsh":"0001231919-25-000533","film_num":["251504124","251504118","251504120","251504119","251504123","251504121","251504122"],"biz_locations":["","Boston, MA","Boston, MA","Boston, MA","Cambridge, MA","Cambridge, MA","Boston, MA","Watertown, MA"],"file_type":"4","file_description":null,"inc_states":["","DE","DE","DE","DE","E9","E9","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001209191-21-055726:doc4.xml","_score":23.198915,"_source":{"ciks":["0001687078","0001691428","0001721036","0001789972"],"period_ending":"2021-09-09","file_num":["001-39856","001-39856","001-39856"],"display_names":["BioImpact Capital LLC  (CIK 0001687078)","UBS Oncology Impact Fund L.P.  (CIK 0001691428)","Oncology Impact Fund (Cayman) Management L.P.  (CIK 0001721036)","Cullinan Oncology, Inc.  (CGEM)  (CIK 0001789972)"],"xsl":"xslF345X03","schema_version":"X0306","sequence":1,"root_forms":["4"],"file_date":"2021-09-13","biz_states":["MA"],"sics":["2836"],"form":"4","adsh":"0001209191-21-055726","film_num":["211250717","211250719","211250718"],"biz_locations":["Cambridge, MA","Cambridge, MA","Cambridge, MA","Cambridge, MA"],"file_type":"4","file_description":"FORM 4 SUBMISSION","inc_states":["DE","E9","E9"],"items":[]}},{"_index":"edgar_file","_id":"0001231919-25-000565:form4-12012025_111237.xml","_score":23.155905,"_source":{"ciks":["0001609492","0001609493","0001609495","0001765021","0001765091","0001785530"],"period_ending":"2025-11-26","file_num":["001-40366","001-40366","001-40366","001-40366","001-40366"],"display_names":["MPM BioVentures 2014, L.P.  (CIK 0001609492)","MPM BioVentures 2014 (B), L.P.  (CIK 0001609493)","MPM Asset Management Investors BV2014 LLC  (CIK 0001609495)","MPM BioVentures 2014 LLC  (CIK 0001765021)","MPM BioVentures 2014 GP LLC  (CIK 0001765091)","Werewolf Therapeutics, Inc.  (CIK 0001785530)"],"xsl":"xslF345X05","schema_version":"X0508","sequence":1,"root_forms":["4"],"file_date":"2025-12-01","biz_states":["MA"],"sics":["2834"],"form":"4","adsh":"0001231919-25-000565","film_num":["251541066","251541065","251541062","251541064","251541063"],"biz_locations":["Boston, MA","Boston, MA","Boston, MA","Boston, MA","Boston, MA","Watertown, MA"],"file_type":"4","file_description":null,"inc_states":["DE","DE","DE","DE","DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001209191-21-056412:doc4.xml","_score":23.148886,"_source":{"ciks":["0001134655","0001687078","0001691428","0001721036","0001808865"],"period_ending":"2021-09-14","file_num":["001-39401","001-39401","001-39401","001-39401"],"display_names":["GADICKE ANSBERT  (CIK 0001134655)","BioImpact Capital LLC  (CIK 0001687078)","UBS Oncology Impact Fund L.P.  (CIK 0001691428)","Oncology Impact Fund (Cayman) Management L.P.  (CIK 0001721036)","iTeos Therapeutics, Inc.  (ITOS)  (CIK 0001808865)"],"xsl":"xslF345X03","schema_version":"X0306","sequence":1,"root_forms":["4"],"file_date":"2021-09-16","biz_states":["MA"],"sics":["2836"],"form":"4","adsh":"0001209191-21-056412","film_num":["211258428","211258426","211258427","211258425"],"biz_locations":["","Cambridge, MA","Cambridge, MA","Cambridge, MA","Cambridge, MA"],"file_type":"4","file_description":"FORM 4 SUBMISSION","inc_states":["","DE","E9","E9","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001209191-21-067146:doc4.xml","_score":23.14645,"_source":{"ciks":["0001134655","0001687078","0001691428","0001721036","0001808865"],"period_ending":"2021-11-26","file_num":["001-39401","001-39401","001-39401","001-39401"],"display_names":["GADICKE ANSBERT  (CIK 0001134655)","BioImpact Capital LLC  (CIK 0001687078)","UBS Oncology Impact Fund L.P.  (CIK 0001691428)","Oncology Impact Fund (Cayman) Management L.P.  (CIK 0001721036)","iTeos Therapeutics, Inc.  (ITOS)  (CIK 0001808865)"],"xsl":"xslF345X03","schema_version":"X0306","sequence":1,"root_forms":["4"],"file_date":"2021-11-30","biz_states":["MA"],"sics":["2836"],"form":"4","adsh":"0001209191-21-067146","film_num":["211460170","211460168","211460169","211460167"],"biz_locations":["","Cambridge, MA","Cambridge, MA","Cambridge, MA","Cambridge, MA"],"file_type":"4","file_description":"FORM 4 SUBMISSION","inc_states":["","DE","E9","E9","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001415889-25-000798:primary_doc.xml","_score":23.14645,"_source":{"ciks":["0001808158","0001609492"],"period_ending":null,"file_num":["005-91542"],"display_names":["Repare Therapeutics Inc.  (RPTX)  (CIK 0001808158)","MPM BioVentures 2014, L.P.  (CIK 0001609492)"],"xsl":"xslSCHEDULE_13D_X01","sequence":1,"root_forms":["SCHEDULE 13D"],"file_date":"2025-01-06","biz_states":["A8","MA"],"sics":["2834"],"form":"SCHEDULE 13D/A","adsh":"0001415889-25-000798","film_num":["25511941"],"biz_locations":["Saint-laurent, A8","Cambridge, MA"],"file_type":"SCHEDULE 13D/A","file_description":null,"inc_states":["Z4","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001193125-23-029989:d317632dsc13ga.htm","_score":23.088417,"_source":{"ciks":["0001262104","0001691428"],"period_ending":null,"file_num":["005-79594"],"display_names":["MEI Pharma, Inc.  (MEIP)  (CIK 0001262104)","UBS Oncology Impact Fund L.P.  (CIK 0001691428)"],"xsl":null,"sequence":1,"root_forms":["SC 13G"],"file_date":"2023-02-09","biz_states":["CA","MA"],"sics":["2834"],"form":"SC 13G/A","adsh":"0001193125-23-029989","film_num":["23606166"],"biz_locations":["San Diego, CA","Cambridge, MA"],"file_type":"SC 13G/A","file_description":"SC 13G/A","inc_states":["DE","E9"],"items":[]}},{"_index":"edgar_file","_id":"0001415889-24-029142:form4-12122024_051204.xml","_score":23.085484,"_source":{"ciks":["0001729505","0001818702","0001818701","0001689375"],"period_ending":"2024-12-10","file_num":["001-40969","001-40969","001-40969"],"display_names":["MPM BIOVENTURES 2018, L.P.  (CIK 0001729505)","MPM BioVentures 2018 LLC  (CIK 0001818702)","MPM BioVentures 2018 GP LLC  (CIK 0001818701)","Entrada Therapeutics, Inc.  (CIK 0001689375)"],"xsl":"xslF345X05","schema_version":"X0508","sequence":1,"root_forms":["4"],"file_date":"2024-12-12","biz_states":["MA"],"sics":["2834"],"form":"4","adsh":"0001415889-24-029142","film_num":["241545709","241545711","241545710"],"biz_locations":["Cambridge, MA","Cambridge, MA","Cambridge, MA","Boston, MA"],"file_type":"4","file_description":null,"inc_states":["DE","DE","DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001415889-25-001117:primary_doc.xml","_score":23.060556,"_source":{"ciks":["0001842952","0001687078"],"period_ending":null,"file_num":["005-93112"],"display_names":["Context Therapeutics Inc.  (CNTX)  (CIK 0001842952)","MPM BioImpact LLC  (CIK 0001687078)"],"xsl":"xslSCHEDULE_13G_X01","sequence":1,"root_forms":["SCHEDULE 13G"],"file_date":"2025-01-08","biz_states":["PA","MA"],"sics":["2834"],"form":"SCHEDULE 13G","adsh":"0001415889-25-001117","film_num":["25518599"],"biz_locations":["Philadelphia, PA","Boston, MA"],"file_type":"SCHEDULE 13G","file_description":null,"inc_states":["DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001807862-24-000001:primary_doc.xml","_score":23.049294,"_source":{"ciks":["0001807862"],"period_ending":null,"file_num":["021-363868"],"display_names":["BioImpact Equities Offshore Fund, Ltd.  (CIK 0001807862)"],"xsl":"xslFormDX01","schema_version":"X0708","sequence":1,"root_forms":["D"],"file_date":"2024-03-08","biz_states":["E9"],"sics":[],"form":"D/A","adsh":"0001807862-24-000001","film_num":["24734375"],"biz_locations":["Grand Cayman, E9"],"file_type":"D/A","file_description":null,"inc_states":["E9"],"items":["06B"]}},{"_index":"edgar_file","_id":"0000929638-25-001068:primary_doc.xml","_score":23.047867,"_source":{"ciks":["0001807862"],"period_ending":null,"file_num":["021-363868"],"display_names":["BioImpact Equities Offshore Fund, Ltd.  (CIK 0001807862)"],"xsl":"xslFormDX01","schema_version":"X0708","sequence":1,"root_forms":["D"],"file_date":"2025-03-10","biz_states":["E9"],"sics":[],"form":"D/A","adsh":"0000929638-25-001068","film_num":["25721586"],"biz_locations":["Grand Cayman, E9"],"file_type":"D/A","file_description":null,"inc_states":["E9"],"items":["06B"]}},{"_index":"edgar_file","_id":"0001609492-26-000004:primary_doc.xml","_score":23.043676,"_source":{"ciks":["0001785530","0001609492"],"period_ending":null,"file_num":["005-92515"],"display_names":["Werewolf Therapeutics, Inc.  (HOWL)  (CIK 0001785530)","MPM BioVentures 2014, L.P.  (CIK 0001609492)"],"xsl":"xslSCHEDULE_13D_X02","schema_version":"X0202","sequence":1,"root_forms":["SCHEDULE 13D"],"file_date":"2026-05-05","biz_states":["MA"],"sics":["2834"],"form":"SCHEDULE 13D/A","adsh":"0001609492-26-000004","film_num":["26945215"],"biz_locations":["Watertown, MA","Boston, MA"],"file_type":"SCHEDULE 13D/A","file_description":null,"inc_states":["DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001415889-25-013244:primary_doc.xml","_score":23.042645,"_source":{"ciks":["0001808865","0001609492"],"period_ending":null,"file_num":["005-91596"],"display_names":["iTeos Therapeutics, Inc.  (ITOS)  (CIK 0001808865)","MPM BioVentures 2014, L.P.  (CIK 0001609492)"],"xsl":"xslSCHEDULE_13D_X01","sequence":1,"root_forms":["SCHEDULE 13D"],"file_date":"2025-05-15","biz_states":["MA"],"sics":["2836"],"form":"SCHEDULE 13D/A","adsh":"0001415889-25-013244","film_num":["25956038"],"biz_locations":["Watertown, MA","Boston, MA"],"file_type":"SCHEDULE 13D/A","file_description":null,"inc_states":["DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001231919-25-000570:primary_doc.xml","_score":23.039646,"_source":{"ciks":["0001785530","0001609492"],"period_ending":null,"file_num":["005-92515"],"display_names":["Werewolf Therapeutics, Inc.  (HOWL)  (CIK 0001785530)","MPM BioVentures 2014, L.P.  (CIK 0001609492)"],"xsl":"xslSCHEDULE_13D_X01","sequence":1,"root_forms":["SCHEDULE 13D"],"file_date":"2025-12-03","biz_states":["MA"],"sics":["2834"],"form":"SCHEDULE 13D/A","adsh":"0001231919-25-000570","film_num":["251547792"],"biz_locations":["Watertown, MA","Boston, MA"],"file_type":"SCHEDULE 13D/A","file_description":null,"inc_states":["DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001209191-21-060235:doc4.xml","_score":22.995598,"_source":{"ciks":["0001134655","0001687078","0001691428","0001721036","0001808865"],"period_ending":"2021-10-07","file_num":["001-39401","001-39401","001-39401","001-39401"],"display_names":["GADICKE ANSBERT  (CIK 0001134655)","BioImpact Capital LLC  (CIK 0001687078)","UBS Oncology Impact Fund L.P.  (CIK 0001691428)","Oncology Impact Fund (Cayman) Management L.P.  (CIK 0001721036)","iTeos Therapeutics, Inc.  (ITOS)  (CIK 0001808865)"],"xsl":"xslF345X03","schema_version":"X0306","sequence":1,"root_forms":["4"],"file_date":"2021-10-12","biz_states":["MA"],"sics":["2836"],"form":"4","adsh":"0001209191-21-060235","film_num":["211318942","211318940","211318941","211318939"],"biz_locations":["","Cambridge, MA","Cambridge, MA","Cambridge, MA","Cambridge, MA"],"file_type":"4","file_description":"FORM 4 SUBMISSION","inc_states":["","DE","E9","E9","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001209191-21-054093:doc4.xml","_score":22.993277,"_source":{"ciks":["0001687078","0001691428","0001721036","0001789972"],"period_ending":"2021-08-23","file_num":["001-39856","001-39856","001-39856"],"display_names":["BioImpact Capital LLC  (CIK 0001687078)","UBS Oncology Impact Fund L.P.  (CIK 0001691428)","Oncology Impact Fund (Cayman) Management L.P.  (CIK 0001721036)","Cullinan Oncology, Inc.  (CGEM)  (CIK 0001789972)"],"xsl":"xslF345X03","schema_version":"X0306","sequence":1,"root_forms":["4"],"file_date":"2021-08-31","biz_states":["MA"],"sics":["2836"],"form":"4","adsh":"0001209191-21-054093","film_num":["211227523","211227525","211227524"],"biz_locations":["Cambridge, MA","Cambridge, MA","Cambridge, MA","Cambridge, MA"],"file_type":"4","file_description":"FORM 4 SUBMISSION","inc_states":["DE","E9","E9"],"items":[]}},{"_index":"edgar_file","_id":"0000950123-21-015060:primary_doc.xml","_score":22.971886,"_source":{"ciks":["0001796461"],"period_ending":"2021-09-30","file_num":["028-20040"],"display_names":["Burrage Capital Management LLC  (CIK 0001796461)"],"xsl":"xslForm13F_X01","sequence":1,"root_forms":["13F-HR"],"file_date":"2021-11-15","biz_states":["MA"],"sics":[],"form":"13F-HR","adsh":"0000950123-21-015060","film_num":["211405665"],"biz_locations":["Boston, MA"],"file_type":"13F-HR","file_description":null,"inc_states":[],"items":[]}},{"_index":"edgar_file","_id":"0000929638-25-002339:primary_doc.xml","_score":22.967402,"_source":{"ciks":["0002028760"],"period_ending":null,"file_num":["021-517266"],"display_names":["MPM BioImpact Innovations Equities Master, LP  (CIK 0002028760)"],"xsl":"xslFormDX01","schema_version":"X0708","sequence":1,"root_forms":["D"],"file_date":"2025-06-27","biz_states":["MA"],"sics":[],"form":"D/A","adsh":"0000929638-25-002339","film_num":["251082707"],"biz_locations":["Boston, MA"],"file_type":"D/A","file_description":null,"inc_states":["DE"],"items":["06B","3C","3C.7"]}},{"_index":"edgar_file","_id":"0001807882-24-000001:primary_doc.xml","_score":22.948977,"_source":{"ciks":["0001807882"],"period_ending":null,"file_num":["021-363866"],"display_names":["BioImpact Equities Fund, LP  (CIK 0001807882)"],"xsl":"xslFormDX01","schema_version":"X0708","sequence":1,"root_forms":["D"],"file_date":"2024-03-08","biz_states":["MA"],"sics":[],"form":"D/A","adsh":"0001807882-24-000001","film_num":["24734285"],"biz_locations":["Boston, MA"],"file_type":"D/A","file_description":null,"inc_states":["DE"],"items":["06B"]}},{"_index":"edgar_file","_id":"0001567619-23-004655:primary_doc.xml","_score":22.948288,"_source":{"ciks":["0001807882"],"period_ending":null,"file_num":["021-363866"],"display_names":["BioImpact Equities Fund, LP  (CIK 0001807882)"],"xsl":"xslFormDX01","schema_version":"X0708","sequence":1,"root_forms":["D"],"file_date":"2023-03-08","biz_states":["MA"],"sics":[],"form":"D/A","adsh":"0001567619-23-004655","film_num":["23715272"],"biz_locations":["Boston, MA"],"file_type":"D/A","file_description":null,"inc_states":["DE"],"items":["06B","3C.7"]}},{"_index":"edgar_file","_id":"0001231919-25-000666:ex-99-12292025_111202.htm","_score":22.94415,"_source":{"ciks":["0001785530","0001609492"],"period_ending":null,"file_num":["005-92515"],"display_names":["Werewolf Therapeutics, Inc.  (HOWL)  (CIK 0001785530)","MPM BioVentures 2014, L.P.  (CIK 0001609492)"],"xsl":null,"sequence":"2","root_forms":["SCHEDULE 13D"],"file_date":"2025-12-29","biz_states":["MA"],"sics":["2834"],"form":"SCHEDULE 13D/A","adsh":"0001231919-25-000666","film_num":["251610739"],"biz_locations":["Watertown, MA","Boston, MA"],"file_type":"EX-99.C","file_description":"JOINT FILING STATEMENT","inc_states":["DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001209191-21-055745:doc4.xml","_score":22.915045,"_source":{"ciks":["0001134655","0001687078","0001691428","0001721036","0001808865"],"period_ending":"2021-09-09","file_num":["001-39401","001-39401","001-39401","001-39401"],"display_names":["GADICKE ANSBERT  (CIK 0001134655)","BioImpact Capital LLC  (CIK 0001687078)","UBS Oncology Impact Fund L.P.  (CIK 0001691428)","Oncology Impact Fund (Cayman) Management L.P.  (CIK 0001721036)","iTeos Therapeutics, Inc.  (ITOS)  (CIK 0001808865)"],"xsl":"xslF345X03","schema_version":"X0306","sequence":1,"root_forms":["4"],"file_date":"2021-09-13","biz_states":["MA"],"sics":["2836"],"form":"4","adsh":"0001209191-21-055745","film_num":["211250822","211250820","211250821","211250819"],"biz_locations":["","Cambridge, MA","Cambridge, MA","Cambridge, MA","Cambridge, MA"],"file_type":"4","file_description":"FORM 4 SUBMISSION","inc_states":["","DE","E9","E9","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001209191-21-068406:doc4.xml","_score":22.833689,"_source":{"ciks":["0001134655","0001687078","0001691428","0001721036","0001808865"],"period_ending":"2021-12-03","file_num":["001-39401","001-39401","001-39401","001-39401"],"display_names":["GADICKE ANSBERT  (CIK 0001134655)","BioImpact Capital LLC  (CIK 0001687078)","UBS Oncology Impact Fund L.P.  (CIK 0001691428)","Oncology Impact Fund (Cayman) Management L.P.  (CIK 0001721036)","iTeos Therapeutics, Inc.  (ITOS)  (CIK 0001808865)"],"xsl":"xslF345X03","schema_version":"X0306","sequence":1,"root_forms":["4"],"file_date":"2021-12-07","biz_states":["MA"],"sics":["2836"],"form":"4","adsh":"0001209191-21-068406","film_num":["211477168","211477166","211477167","211477165"],"biz_locations":["","Cambridge, MA","Cambridge, MA","Cambridge, MA","Cambridge, MA"],"file_type":"4","file_description":"FORM 4 SUBMISSION","inc_states":["","DE","E9","E9","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001609492-26-000006:primary_doc.xml","_score":22.799557,"_source":{"ciks":["0001785530","0001609492"],"period_ending":null,"file_num":["005-92515"],"display_names":["Werewolf Therapeutics, Inc.  (HOWL)  (CIK 0001785530)","MPM BioVentures 2014, L.P.  (CIK 0001609492)"],"xsl":"xslSCHEDULE_13D_X02","schema_version":"X0202","sequence":1,"root_forms":["SCHEDULE 13D"],"file_date":"2026-05-12","biz_states":["MA"],"sics":["2834"],"form":"SCHEDULE 13D/A","adsh":"0001609492-26-000006","film_num":["26970438"],"biz_locations":["Watertown, MA","Boston, MA"],"file_type":"SCHEDULE 13D/A","file_description":null,"inc_states":["DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001209191-21-060489:doc4.xml","_score":22.786741,"_source":{"ciks":["0001134655","0001687078","0001691428","0001721036","0001808865"],"period_ending":"2021-10-12","file_num":["001-39401","001-39401","001-39401","001-39401"],"display_names":["GADICKE ANSBERT  (CIK 0001134655)","BioImpact Capital LLC  (CIK 0001687078)","UBS Oncology Impact Fund L.P.  (CIK 0001691428)","Oncology Impact Fund (Cayman) Management L.P.  (CIK 0001721036)","iTeos Therapeutics, Inc.  (ITOS)  (CIK 0001808865)"],"xsl":"xslF345X03","schema_version":"X0306","sequence":1,"root_forms":["4"],"file_date":"2021-10-14","biz_states":["MA"],"sics":["2836"],"form":"4","adsh":"0001209191-21-060489","film_num":["211324084","211324082","211324083","211324081"],"biz_locations":["","Cambridge, MA","Cambridge, MA","Cambridge, MA","Cambridge, MA"],"file_type":"4","file_description":"FORM 4 SUBMISSION","inc_states":["","DE","E9","E9","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001231919-25-000374:form4-10292025_111051.xml","_score":22.731256,"_source":{"ciks":["0001609492","0001609493","0001609495","0001765021","0001765091","0001785530"],"period_ending":"2025-10-27","file_num":["001-40366","001-40366","001-40366","001-40366","001-40366"],"display_names":["MPM BioVentures 2014, L.P.  (CIK 0001609492)","MPM BioVentures 2014 (B), L.P.  (CIK 0001609493)","MPM Asset Management Investors BV2014 LLC  (CIK 0001609495)","MPM BioVentures 2014 LLC  (CIK 0001765021)","MPM BioVentures 2014 GP LLC  (CIK 0001765091)","Werewolf Therapeutics, Inc.  (CIK 0001785530)"],"xsl":"xslF345X05","schema_version":"X0508","sequence":1,"root_forms":["4"],"file_date":"2025-10-29","biz_states":["MA"],"sics":["2834"],"form":"4","adsh":"0001231919-25-000374","film_num":["251431643","251431642","251431639","251431641","251431640"],"biz_locations":["Boston, MA","Boston, MA","Boston, MA","Boston, MA","Boston, MA","Watertown, MA"],"file_type":"4","file_description":null,"inc_states":["DE","DE","DE","DE","DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0000929638-26-000950:primary_doc.xml","_score":22.717655,"_source":{"ciks":["0001807862"],"period_ending":null,"file_num":["021-363868"],"display_names":["BioImpact Equities Offshore Fund, Ltd.  (CIK 0001807862)"],"xsl":"xslFormDX01","schema_version":"X0708","sequence":1,"root_forms":["D"],"file_date":"2026-03-10","biz_states":["E9"],"sics":[],"form":"D/A","adsh":"0000929638-26-000950","film_num":["26738889"],"biz_locations":["Grand Cayman, E9"],"file_type":"D/A","file_description":null,"inc_states":["E9"],"items":["06B"]}},{"_index":"edgar_file","_id":"0001687078-26-000018:primary_doc.xml","_score":22.71703,"_source":{"ciks":["0001768446","0001687078"],"period_ending":null,"file_num":["005-92797"],"display_names":["Climb Bio, Inc.  (CLYM)  (CIK 0001768446)","MPM BioImpact LLC  (CIK 0001687078)"],"xsl":"xslSCHEDULE_13G_X02","schema_version":"X0202","sequence":1,"root_forms":["SCHEDULE 13G"],"file_date":"2026-08-14","biz_states":["MA"],"sics":["2834"],"form":"SCHEDULE 13G/A","adsh":"0001687078-26-000018","film_num":["261281023"],"biz_locations":["Wellesley Hills, MA","Boston, MA"],"file_type":"SCHEDULE 13G/A","file_description":null,"inc_states":["DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001687078-26-000020:primary_doc.xml","_score":22.71703,"_source":{"ciks":["0001842952","0001687078"],"period_ending":null,"file_num":["005-93112"],"display_names":["Context Therapeutics Inc.  (CNTX)  (CIK 0001842952)","MPM BioImpact LLC  (CIK 0001687078)"],"xsl":"xslSCHEDULE_13G_X02","schema_version":"X0202","sequence":1,"root_forms":["SCHEDULE 13G"],"file_date":"2026-08-14","biz_states":["PA","MA"],"sics":["2834"],"form":"SCHEDULE 13G/A","adsh":"0001687078-26-000020","film_num":["261281066"],"biz_locations":["Philadelphia, PA","Boston, MA"],"file_type":"SCHEDULE 13G/A","file_description":null,"inc_states":["DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001415889-25-001509:primary_doc.xml","_score":22.708689,"_source":{"ciks":["0001808158","0001609492"],"period_ending":null,"file_num":["005-91542"],"display_names":["Repare Therapeutics Inc.  (RPTX)  (CIK 0001808158)","MPM BioVentures 2014, L.P.  (CIK 0001609492)"],"xsl":"xslSCHEDULE_13D_X01","sequence":1,"root_forms":["SCHEDULE 13D"],"file_date":"2025-01-15","biz_states":["A8","MA"],"sics":["2834"],"form":"SCHEDULE 13D/A","adsh":"0001415889-25-001509","film_num":["25533970"],"biz_locations":["Saint-laurent, A8","Cambridge, MA"],"file_type":"SCHEDULE 13D/A","file_description":null,"inc_states":["Z4","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001231919-25-000422:primary_doc.xml","_score":22.66196,"_source":{"ciks":["0001785530","0001609492"],"period_ending":null,"file_num":["005-92515"],"display_names":["Werewolf Therapeutics, Inc.  (HOWL)  (CIK 0001785530)","MPM BioVentures 2014, L.P.  (CIK 0001609492)"],"xsl":"xslSCHEDULE_13D_X01","sequence":1,"root_forms":["SCHEDULE 13D"],"file_date":"2025-11-04","biz_states":["MA"],"sics":["2834"],"form":"SCHEDULE 13D/A","adsh":"0001231919-25-000422","film_num":["251451114"],"biz_locations":["Watertown, MA","Boston, MA"],"file_type":"SCHEDULE 13D/A","file_description":null,"inc_states":["DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001415889-25-002471:ex-1-01312025_090159.htm","_score":22.658821,"_source":{"ciks":["0001808158","0001609492"],"period_ending":null,"file_num":["005-91542"],"display_names":["Repare Therapeutics Inc.  (RPTX)  (CIK 0001808158)","MPM BioVentures 2014, L.P.  (CIK 0001609492)"],"xsl":null,"sequence":"2","root_forms":["SCHEDULE 13D"],"file_date":"2025-01-31","biz_states":["A8","MA"],"sics":["2834"],"form":"SCHEDULE 13D/A","adsh":"0001415889-25-002471","film_num":["25578566"],"biz_locations":["Saint-laurent, A8","Boston, MA"],"file_type":"EX-1","file_description":"JOINT FILING STATEMENT","inc_states":["Z4","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001209191-21-058208:doc4.xml","_score":22.648104,"_source":{"ciks":["0001134655","0001687078","0001691428","0001721036","0001808865"],"period_ending":"2021-09-28","file_num":["001-39401","001-39401","001-39401","001-39401"],"display_names":["GADICKE ANSBERT  (CIK 0001134655)","BioImpact Capital LLC  (CIK 0001687078)","UBS Oncology Impact Fund L.P.  (CIK 0001691428)","Oncology Impact Fund (Cayman) Management L.P.  (CIK 0001721036)","iTeos Therapeutics, Inc.  (ITOS)  (CIK 0001808865)"],"xsl":"xslF345X03","schema_version":"X0306","sequence":1,"root_forms":["4"],"file_date":"2021-09-30","biz_states":["MA"],"sics":["2836"],"form":"4","adsh":"0001209191-21-058208","film_num":["211295698","211295696","211295697","211295695"],"biz_locations":["","Cambridge, MA","Cambridge, MA","Cambridge, MA","Cambridge, MA"],"file_type":"4","file_description":"FORM 4 SUBMISSION","inc_states":["","DE","E9","E9","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001687078-26-000012:primary_doc.xml","_score":22.614016,"_source":{"ciks":["0001613780","0001687078"],"period_ending":null,"file_num":["005-88701"],"display_names":["DBV Technologies S.A.  (DBVT, DBVTF)  (CIK 0001613780)","MPM BioImpact LLC  (CIK 0001687078)"],"xsl":"xslSCHEDULE_13G_X02","schema_version":"X0202","sequence":1,"root_forms":["SCHEDULE 13G"],"file_date":"2026-05-15","biz_states":["I0","MA"],"sics":["2836"],"form":"SCHEDULE 13G/A","adsh":"0001687078-26-000012","film_num":["26987336"],"biz_locations":["Chatillon, I0","Boston, MA"],"file_type":"SCHEDULE 13G/A","file_description":null,"inc_states":["I0","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001231919-26-001156:form4-09092026_110910.xml","_score":22.560085,"_source":{"ciks":["0001729505","0001818702","0001818701","0001689375"],"period_ending":"2026-09-04","file_num":["001-40969","001-40969","001-40969"],"display_names":["MPM BIOVENTURES 2018, L.P.  (CIK 0001729505)","MPM BioVentures 2018 LLC  (CIK 0001818702)","MPM BioVentures 2018 GP LLC  (CIK 0001818701)","Entrada Therapeutics, Inc.  (CIK 0001689375)"],"xsl":"xslF345X06","schema_version":"X0609","sequence":1,"root_forms":["4"],"file_date":"2026-09-09","biz_states":["MA"],"sics":["2834"],"form":"4","adsh":"0001231919-26-001156","film_num":["261369334","261369333","261369332"],"biz_locations":["Cambridge, MA","Cambridge, MA","Boston, MA","Boston, MA"],"file_type":"4","file_description":null,"inc_states":["DE","DE","DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001231919-26-001136:form4-08312026_100804.xml","_score":22.556711,"_source":{"ciks":["0001729505","0001818702","0001818701","0001689375"],"period_ending":"2026-08-27","file_num":["001-40969","001-40969","001-40969"],"display_names":["MPM BIOVENTURES 2018, L.P.  (CIK 0001729505)","MPM BioVentures 2018 LLC  (CIK 0001818702)","MPM BioVentures 2018 GP LLC  (CIK 0001818701)","Entrada Therapeutics, Inc.  (CIK 0001689375)"],"xsl":"xslF345X06","schema_version":"X0609","sequence":1,"root_forms":["4"],"file_date":"2026-08-31","biz_states":["MA"],"sics":["2834"],"form":"4","adsh":"0001231919-26-001136","film_num":["261348054","261348053","261348052"],"biz_locations":["Cambridge, MA","Cambridge, MA","Boston, MA","Boston, MA"],"file_type":"4","file_description":null,"inc_states":["DE","DE","DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001438934-25-000683:primary_doc.xml","_score":22.556103,"_source":{"ciks":["0001687078"],"period_ending":"2025-06-30","file_num":["028-20107"],"display_names":["MPM BioImpact LLC  (CIK 0001687078)"],"xsl":"xslN-PX_X01","sequence":1,"root_forms":["N-PX"],"file_date":"2025-08-12","biz_states":["MA"],"sics":[],"form":"N-PX","adsh":"0001438934-25-000683","film_num":["251204828"],"biz_locations":["Boston, MA"],"file_type":"N-PX","file_description":null,"inc_states":["DE"],"items":[]}},{"_index":"edgar_file","_id":"0001209191-21-055212:doc4.xml","_score":22.550772,"_source":{"ciks":["0001134655","0001687078","0001691428","0001721036","0001808865"],"period_ending":"2021-09-07","file_num":["001-39401","001-39401","001-39401","001-39401"],"display_names":["GADICKE ANSBERT  (CIK 0001134655)","BioImpact Capital LLC  (CIK 0001687078)","UBS Oncology Impact Fund L.P.  (CIK 0001691428)","Oncology Impact Fund (Cayman) Management L.P.  (CIK 0001721036)","iTeos Therapeutics, Inc.  (ITOS)  (CIK 0001808865)"],"xsl":"xslF345X03","schema_version":"X0306","sequence":1,"root_forms":["4"],"file_date":"2021-09-08","biz_states":["MA"],"sics":["2836"],"form":"4","adsh":"0001209191-21-055212","film_num":["211243243","211243241","211243242","211243240"],"biz_locations":["","Cambridge, MA","Cambridge, MA","Cambridge, MA","Cambridge, MA"],"file_type":"4","file_description":"FORM 4 SUBMISSION","inc_states":["","DE","E9","E9","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001415889-25-011574:form4-04302025_080449.xml","_score":22.535542,"_source":{"ciks":["0001473930","0001609492","0001609493","0001609495","0001765021","0001765091","0001785530"],"period_ending":"2025-03-27","file_num":["001-40366","001-40366","001-40366","001-40366","001-40366","001-40366"],"display_names":["Foley Todd  (CIK 0001473930)","MPM BioVentures 2014, L.P.  (CIK 0001609492)","MPM BioVentures 2014 (B), L.P.  (CIK 0001609493)","MPM Asset Management Investors BV2014 LLC  (CIK 0001609495)","MPM BioVentures 2014 LLC  (CIK 0001765021)","MPM BioVentures 2014 GP LLC  (CIK 0001765091)","Werewolf Therapeutics, Inc.  (CIK 0001785530)"],"xsl":"xslF345X05","schema_version":"X0508","sequence":1,"root_forms":["4"],"file_date":"2025-04-30","biz_states":["MA"],"sics":["2834"],"form":"4","adsh":"0001415889-25-011574","film_num":["25895578","25895583","25895582","25895579","25895581","25895580"],"biz_locations":["","Boston, MA","Boston, MA","Boston, MA","Boston, MA","Boston, MA","Watertown, MA"],"file_type":"4","file_description":null,"inc_states":["","DE","DE","DE","DE","DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001209191-21-057822:doc4.xml","_score":22.513002,"_source":{"ciks":["0001134655","0001687078","0001691428","0001721036","0001808865"],"period_ending":"2021-09-23","file_num":["001-39401","001-39401","001-39401","001-39401"],"display_names":["GADICKE ANSBERT  (CIK 0001134655)","BioImpact Capital LLC  (CIK 0001687078)","UBS Oncology Impact Fund L.P.  (CIK 0001691428)","Oncology Impact Fund (Cayman) Management L.P.  (CIK 0001721036)","iTeos Therapeutics, Inc.  (ITOS)  (CIK 0001808865)"],"xsl":"xslF345X03","schema_version":"X0306","sequence":1,"root_forms":["4"],"file_date":"2021-09-27","biz_states":["MA"],"sics":["2836"],"form":"4","adsh":"0001209191-21-057822","film_num":["211282996","211282994","211282995","211282993"],"biz_locations":["","Cambridge, MA","Cambridge, MA","Cambridge, MA","Cambridge, MA"],"file_type":"4","file_description":"FORM 4 SUBMISSION","inc_states":["","DE","E9","E9","DE"],"items":[]}},{"_index":"edgar_file","_id":"0000929638-26-002366:primary_doc.xml","_score":22.479832,"_source":{"ciks":["0002028760"],"period_ending":null,"file_num":["021-517266"],"display_names":["MPM BioImpact Innovations Equities Master, LP  (CIK 0002028760)"],"xsl":"xslFormDX01","schema_version":"X0708","sequence":1,"root_forms":["D"],"file_date":"2026-06-26","biz_states":["MA"],"sics":[],"form":"D/A","adsh":"0000929638-26-002366","film_num":["261127995"],"biz_locations":["Boston, MA"],"file_type":"D/A","file_description":null,"inc_states":["DE"],"items":["06B","3C","3C.7"]}},{"_index":"edgar_file","_id":"0001415889-25-021493:primary_doc.xml","_score":22.447111,"_source":{"ciks":["0001738021","0001687078"],"period_ending":null,"file_num":["005-90878"],"display_names":["Compass Therapeutics, Inc.  (CMPX)  (CIK 0001738021)","MPM BioImpact LLC  (CIK 0001687078)"],"xsl":"xslSCHEDULE_13G_X01","sequence":1,"root_forms":["SCHEDULE 13G"],"file_date":"2025-08-12","biz_states":["MA"],"sics":["2836"],"form":"SCHEDULE 13G/A","adsh":"0001415889-25-021493","film_num":["251207179"],"biz_locations":["Boston, MA","Boston, MA"],"file_type":"SCHEDULE 13G/A","file_description":null,"inc_states":["DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001231919-26-000025:form3-01092026_020131.xml","_score":22.414291,"_source":{"ciks":["0001134655","0002104306","0001263048","0002035832"],"period_ending":"2026-01-08","file_num":["001-43047","001-43047","001-43047"],"display_names":["GADICKE ANSBERT  (CIK 0001134655)","Oncology Impact Private Investment Fund 2, L.P.  (CIK 0002104306)","MPM ASSET MANAGEMENT LLC  (CIK 0001263048)","Aktis Oncology, Inc.  (CIK 0002035832)"],"xsl":"xslF345X02","schema_version":"X0206","sequence":1,"root_forms":["3"],"file_date":"2026-01-08","biz_states":["MA"],"sics":["2834"],"form":"3","adsh":"0001231919-26-000025","film_num":["26521191","26521189","26521190"],"biz_locations":["","Grand Cayman","Boston, MA","Boston, MA"],"file_type":"3","file_description":null,"inc_states":["","E9","DE","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001415889-25-000798:ex-1-01062025_090131.htm","_score":22.372452,"_source":{"ciks":["0001808158","0001609492"],"period_ending":null,"file_num":["005-91542"],"display_names":["Repare Therapeutics Inc.  (RPTX)  (CIK 0001808158)","MPM BioVentures 2014, L.P.  (CIK 0001609492)"],"xsl":null,"sequence":"2","root_forms":["SCHEDULE 13D"],"file_date":"2025-01-06","biz_states":["A8","MA"],"sics":["2834"],"form":"SCHEDULE 13D/A","adsh":"0001415889-25-000798","film_num":["25511941"],"biz_locations":["Saint-laurent, A8","Cambridge, MA"],"file_type":"EX-1","file_description":"JOINT FILING STATEMENT","inc_states":["Z4","DE"],"items":[]}},{"_index":"edgar_file","_id":"0001231919-25-000422:ex-99-11042025_111142.htm","_score":22.336498,"_source":{"ciks":["0001785530","0001609492"],"period_ending":null,"file_num":["005-92515"],"display_names":["Werewolf Therapeutics, Inc.  (HOWL)  (CIK 0001785530)","MPM BioVentures 2014, L.P.  (CIK 0001609492)"],"xsl":null,"sequence":"3","root_forms":["SCHEDULE 13D"],"file_date":"2025-11-04","biz_states":["MA"],"sics":["2834"],"form":"SCHEDULE 13D/A","adsh":"0001231919-25-000422","film_num":["251451114"],"biz_locations":["Watertown, MA","Boston, MA"],"file_type":"EX-99.C","file_description":"JOINT FILING STATEMENT","inc_states":["DE","DE"],"items":[]}}]},"aggregations":{"entity_filter":{"doc_count_error_upper_bound":0,"sum_other_doc_count":84,"buckets":[{"key":"MPM BioVentures 2014, L.P.  (CIK 0001609492)","doc_count":52},{"key":"Werewolf Therapeutics, Inc.  (CIK 0001785530)","doc_count":46},{"key":"GADICKE ANSBERT  (CIK 0001134655)","doc_count":43},{"key":"EVNIN LUKE  (CIK 0001134657)","doc_count":40},{"key":"MPM BioImpact LLC  (CIK 0001687078)","doc_count":37},{"key":"UBS Oncology Impact Fund L.P.  (CIK 0001691428)","doc_count":36},{"key":"BioImpact Capital LLC  (CIK 0001687078)","doc_count":35},{"key":"Oncology Impact Fund (Cayman) Management L.P.  (CIK 0001721036)","doc_count":34},{"key":"Reunion Neuroscience Inc.  (CIK 0001865482)","doc_count":34},{"key":"Werewolf Therapeutics, Inc.  (HOWL)  (CIK 0001785530)","doc_count":27},{"key":"iTeos Therapeutics, Inc.  (ITOS)  (CIK 0001808865)","doc_count":24},{"key":"Cullinan Oncology, Inc.  (CGEM)  (CIK 0001789972)","doc_count":18},{"key":"Aktis Oncology, Inc.  (CIK 0002035832)","doc_count":16},{"key":"MPM Asset Management Investors BV2014 LLC  (CIK 0001609495)","doc_count":16},{"key":"MPM BioVentures 2014 (B), L.P.  (CIK 0001609493)","doc_count":16},{"key":"MPM BioVentures 2014 GP LLC  (CIK 0001765091)","doc_count":16},{"key":"MPM BioVentures 2014 LLC  (CIK 0001765021)","doc_count":16},{"key":"MPM ASSET MANAGEMENT LLC  (CIK 0001263048)","doc_count":12},{"key":"MPM ONCOLOGY INNOVATIONS FUND LP  (CIK 0001719960)","doc_count":12},{"key":"MPM Oncology Innovations Fund GP LLC  (CIK 0001857903)","doc_count":12},{"key":"DBV Technologies S.A.  (DBVT, DBVTF)  (CIK 0001613780)","doc_count":10},{"key":"Entrada Therapeutics, Inc.  (CIK 0001689375)","doc_count":10},{"key":"Repare Therapeutics Inc.  (RPTX)  (CIK 0001808158)","doc_count":10},{"key":"Foley Todd  (CIK 0001473930)","doc_count":9},{"key":"MPM BIOVENTURES 2018, L.P.  (CIK 0001729505)","doc_count":9},{"key":"Context Therapeutics Inc.  (CNTX)  (CIK 0001842952)","doc_count":8},{"key":"MPM ASSET MANAGEMENT INVESTORS BV2018 LLC  (CIK 0001734817)","doc_count":8},{"key":"MPM BIOVENTURES 2018 (B), L.P.  (CIK 0001729504)","doc_count":8},{"key":"MPM BioVentures 2018 GP LLC  (CIK 0001818701)","doc_count":8},{"key":"MPM BioVentures 2018 LLC  (CIK 0001818702)","doc_count":8}]},"sic_filter":{"doc_count_error_upper_bound":0,"sum_other_doc_count":0,"buckets":[{"key":"2834","doc_count":159},{"key":"2836","doc_count":75},{"key":"8000","doc_count":34}]},"biz_states_filter":{"doc_count_error_upper_bound":0,"sum_other_doc_count":0,"buckets":[{"key":"MA","doc_count":223},{"key":"A6","doc_count":34},{"key":"I0","doc_count":12},{"key":"CA","doc_count":11},{"key":"A8","doc_count":10},{"key":"E9","doc_count":8},{"key":"PA","doc_count":8},{"key":"CT","doc_count":7},{"key":"NY","doc_count":4},{"key":"NJ","doc_count":2},{"key":"A1","doc_count":1},{"key":"CO","doc_count":1},{"key":"TX","doc_count":1}]},"form_filter":{"doc_count_error_upper_bound":0,"sum_other_doc_count":0,"buckets":[{"key":"4","doc_count":99},{"key":"SCHEDULE 13D","doc_count":29},{"key":"6-K","doc_count":26},{"key":"DEF 14A","doc_count":22},{"key":"13F-HR","doc_count":21},{"key":"D","doc_count":16},{"key":"SC 13D","doc_count":12},{"key":"8-K","doc_count":11},{"key":"SCHEDULE 13G","doc_count":11},{"key":"10-K","doc_count":8},{"key":"PRE 14A","doc_count":7},{"key":"DRS","doc_count":6},{"key":"S-1","doc_count":6},{"key":"40-F","doc_count":5},{"key":"S-4","doc_count":5},{"key":"3","doc_count":3},{"key":"424B3","doc_count":3},{"key":"N-PX","doc_count":3},{"key":"PRER14A","doc_count":3},{"key":"ARS","doc_count":2},{"key":"SC 13G","doc_count":2},{"key":"10-Q","doc_count":1},{"key":"424B4","doc_count":1},{"key":"5","doc_count":1},{"key":"DEFM14A","doc_count":1},{"key":"F-3","doc_count":1},{"key":"POS AM","doc_count":1},{"key":"PREM14A","doc_count":1},{"key":"S-3","doc_count":1}]}},"query":{"_source":{"exclude":["doc_text"]},"query":{"bool":{"must":[{"match_phrase":{"doc_text":"Bioimpact"}}],"must_not":[],"should":[],"filter":[]}},"from":0,"size":100,"aggregations":{"form_filter":{"terms":{"field":"root_forms","size":30}},"entity_filter":{"terms":{"field":"display_names.raw","size":30}},"sic_filter":{"terms":{"field":"sics","size":30}},"biz_states_filter":{"terms":{"field":"biz_states","size":30}}}}}